
<html lang="en"     class="pb-page"  data-request-id="c8f9e66f-7a0c-4908-bf8f-c2b6f39e505a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2018.61.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.7b00844"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of an Orally Bioavailable Benzofuran Analogue That Serves as a β-Amyloid Aggregation Inhibitor for the Potential Treatment of Alzheimer’s Disease" /></meta><meta name="dc.Creator" content="Hee-Jin  Ha" /></meta><meta name="dc.Creator" content="Dong Wook  Kang" /></meta><meta name="dc.Creator" content="Hyuk-Min  Kim" /></meta><meta name="dc.Creator" content="Jin-Mi  Kang" /></meta><meta name="dc.Creator" content="Jihyae  Ann" /></meta><meta name="dc.Creator" content="Hyae Jung  Hyun" /></meta><meta name="dc.Creator" content="Joon Hwan  Lee" /></meta><meta name="dc.Creator" content="Sae Hee  Kim" /></meta><meta name="dc.Creator" content="Hee  Kim" /></meta><meta name="dc.Creator" content="Kwanghyun  Choi" /></meta><meta name="dc.Creator" content="Hyun-Seok  Hong" /></meta><meta name="dc.Creator" content="YoungHo  Kim" /></meta><meta name="dc.Creator" content="Dong-Gyu  Jo" /></meta><meta name="dc.Creator" content="Jiyoun  Lee" /></meta><meta name="dc.Creator" content="Jeewoo  Lee" /></meta><meta name="dc.Description" content="We developed an orally active and blood–brain-barrier-permeable benzofuran analogue (8, MDR-1339) with potent antiaggregation activity. Compound 8 restored cellular viability from Aβ-induced cytoto..." /></meta><meta name="Description" content="We developed an orally active and blood–brain-barrier-permeable benzofuran analogue (8, MDR-1339) with potent antiaggregation activity. Compound 8 restored cellular viability from Aβ-induced cytoto..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 6, 2017" /></meta><meta name="dc.Type" content="rapid-communication" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00844" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00844" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00844" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00844" /></link>
        
    
    

<title>Discovery of an Orally Bioavailable Benzofuran Analogue That Serves as a β-Amyloid Aggregation Inhibitor for the Potential Treatment of Alzheimer’s Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00844" /></meta><meta property="og:title" content="Discovery of an Orally Bioavailable Benzofuran Analogue That Serves as a β-Amyloid Aggregation Inhibitor for the Potential Treatment of Alzheimer’s Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0010.jpeg" /></meta><meta property="og:description" content="We developed an orally active and blood–brain-barrier-permeable benzofuran analogue (8, MDR-1339) with potent antiaggregation activity. Compound 8 restored cellular viability from Aβ-induced cytotoxicity but also improved the learning and memory function of AD model mice by reducing the Aβ aggregates in the brains. Given the high bioavailability and brain permeability demonstrated in our pharmacokinetic studies, 8 will provide a novel scaffold for an Aβ-aggregation inhibitor that may offer an alternative treatment for AD." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00844"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00844">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00844&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00844&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00844&amp;href=/doi/10.1021/acs.jmedchem.7b00844" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 396-402</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01671" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Brief Article</span><a href="/doi/10.1021/jmv061i001_1160373" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of an Orally Bioavailable Benzofuran Analogue That Serves as a β-Amyloid Aggregation Inhibitor for the Potential Treatment of Alzheimer’s Disease</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hee-Jin++Ha">Hee-Jin Ha</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dong+Wook++Kang">Dong Wook Kang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hyuk-Min++Kim">Hyuk-Min Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jin-Mi++Kang">Jin-Mi Kang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jihyae++Ann">Jihyae Ann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hyae+Jung++Hyun">Hyae Jung Hyun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joon+Hwan++Lee">Joon Hwan Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sae+Hee++Kim">Sae Hee Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hee++Kim">Hee Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kwanghyun++Choi">Kwanghyun Choi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hyun-Seok++Hong">Hyun-Seok Hong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=YoungHo++Kim">YoungHo Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dong-Gyu++Jo">Dong-Gyu Jo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiyoun++Lee">Jiyoun Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeewoo++Lee">Jeewoo Lee</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7832-6719" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Laboratory of Medicinal Chemistry, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Medifron DBT, Sandanro 349, Danwon-gu, Ansan-si, Gyeonggi-do 15426, Republic of Korea</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do 16419, Republic of Korea</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Daewoong Pharmaceutical, 72 Dugye-ro, Pogok-eup, Cheoin-gu, Yongin-si, Gyeonggi-do 17028, Republic of Korea</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Global Medical Science, Sungshin University, 76 Dobong-ro, Gangbuk-gu, Seoul 01133, Republic of Korea</span></div><div class="corresp-info"><strong>*</strong>Phone: 82-2-880-7846. E-mail: <a href="/cdn-cgi/l/email-protection#87ede2e2f0e8e8c7f4e9f2a9e6e4a9ecf5"><span class="__cf_email__" data-cfemail="ea808f8f9d8585aa99849fc48b89c48198">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00844&amp;href=/doi/10.1021%2Facs.jmedchem.7b00844" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 396–402</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 21, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 June 2017</li><li><span class="item_label"><b>Published</b> online</span>6 December 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 January 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00844" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00844</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D396%26pageCount%3D7%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHee-Jin%2BHa%252C%2BDong%2BWook%2BKang%252C%2BHyuk-Min%2BKim%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D1%26contentID%3Dacs.jmedchem.7b00844%26title%3DDiscovery%2Bof%2Ban%2BOrally%2BBioavailable%2BBenzofuran%2BAnalogue%2BThat%2BServes%2Bas%2Ba%2B%25CE%25B2-Amyloid%2BAggregation%2BInhibitor%2Bfor%2Bthe%2BPotential%2BTreatment%2Bof%2BAlzheimer%25E2%2580%2599s%2BDisease%26numPages%3D7%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D402%26publicationDate%3DJanuary%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00844"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2373</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00844" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of an Orally Bioavailable Benzofuran Analogue That Serves as a β-Amyloid Aggregation Inhibitor for the Potential Treatment of Alzheimer’s Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hee-Jin&quot;,&quot;last_name&quot;:&quot;Ha&quot;},{&quot;first_name&quot;:&quot;Dong&quot;,&quot;last_name&quot;:&quot;Wook Kang&quot;},{&quot;first_name&quot;:&quot;Hyuk-Min&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Jin-Mi&quot;,&quot;last_name&quot;:&quot;Kang&quot;},{&quot;first_name&quot;:&quot;Jihyae&quot;,&quot;last_name&quot;:&quot;Ann&quot;},{&quot;first_name&quot;:&quot;Hyae&quot;,&quot;last_name&quot;:&quot;Jung Hyun&quot;},{&quot;first_name&quot;:&quot;Joon&quot;,&quot;last_name&quot;:&quot;Hwan Lee&quot;},{&quot;first_name&quot;:&quot;Sae&quot;,&quot;last_name&quot;:&quot;Hee Kim&quot;},{&quot;first_name&quot;:&quot;Hee&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Kwanghyun&quot;,&quot;last_name&quot;:&quot;Choi&quot;},{&quot;first_name&quot;:&quot;Hyun-Seok&quot;,&quot;last_name&quot;:&quot;Hong&quot;},{&quot;first_name&quot;:&quot;YoungHo&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Dong-Gyu&quot;,&quot;last_name&quot;:&quot;Jo&quot;},{&quot;first_name&quot;:&quot;Jiyoun&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Jeewoo&quot;,&quot;last_name&quot;:&quot;Lee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;396-402&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00844&quot;},&quot;abstract&quot;:&quot;We developed an orally active and blood–brain-barrier-permeable benzofuran analogue (8, MDR-1339) with potent antiaggregation activity. Compound 8 restored cellular viability from Aβ-induced cytotoxicity but also improved the learning and memory function of AD model mice by reducing the Aβ aggregates in the brains. Given the high bioavailability and brain permeability demonstrated in our pharmacokinetic studies, 8 will provide a novel scaffold for an Aβ-aggregation inhibitor that may offer an alternative treatment for AD.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00844&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00844" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00844&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00844" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00844&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00844" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00844&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00844&amp;href=/doi/10.1021/acs.jmedchem.7b00844" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00844" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00844" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00844%26sid%3Dliteratum%253Aachs%26pmid%3D29161514%26genre%3Darticle%26aulast%3DHa%26date%3D2018%26atitle%3DDiscovery%2Bof%2Ban%2BOrally%2BBioavailable%2BBenzofuran%2BAnalogue%2BThat%2BServes%2Bas%2Ba%2B%25CE%25B2-Amyloid%2BAggregation%2BInhibitor%2Bfor%2Bthe%2BPotential%2BTreatment%2Bof%2BAlzheimer%25E2%2580%2599s%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D1%26spage%3D396%26epage%3D402%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=290645" title="Aggregation">Aggregation</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/jmcmar.2018.61.issue-1/20180111/jmcmar.2018.61.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We developed an orally active and blood–brain-barrier-permeable benzofuran analogue (<b>8</b>, MDR-1339) with potent antiaggregation activity. Compound <b>8</b> restored cellular viability from Aβ-induced cytotoxicity but also improved the learning and memory function of AD model mice by reducing the Aβ aggregates in the brains. Given the high bioavailability and brain permeability demonstrated in our pharmacokinetic studies, <b>8</b> will provide a novel scaffold for an Aβ-aggregation inhibitor that may offer an alternative treatment for AD.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26266" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26266" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Protein aggregation, once thought to be a rare phenomenon in living organisms, not only occurs ubiquitously but also contributes to the pathogenesis of more than 50 human diseases.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Though complete mechanisms of how protein aggregates are formed and how these aggregates are involved in the etiology of various diseases have not been fully understood, age-related impairment of protein quality control has been suspected as a major factor in these processes, which accounts for the fact that many disease markers found in senile disorders are protein aggregates. For example, amylin in type II diabetes, α-synuclein in Parkinson’s disease, and amyloid β (Aβ) peptides in Alzheimer’s disease (AD) form insoluble fibers or toxic soluble oligomers, which cause the loss of normal cellular function and accelerate aggregation even further.</div><div class="NLM_p">Among these pathogenic aggregates, Aβ peptides are probably the most extensively studied because they are central to the amyloid hypothesis, one of the leading theories of AD pathogenesis.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Many anti-amyloid therapies, such as β- and γ-secretase inhibitors, anti-Aβ antibodies, and protein aggregation inhibitors, have been developed and tested as potential treatment options for AD. However, recent clinical trial failures cast doubt on the validity of these therapies. It has been suggested that secretase inhibitors suppress various other pathways in the brain and the peripheral tissues, exhibiting severe side effects;<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> anti-Aβ antibodies might be trapped in the bloodstream, allowing only limited quantities to reach the target.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Despite these clinical trial failures, anti-amyloid therapies are still considered to be a promising alternative to currently available AD treatments because they have the potential to slow down or prevent neurodegeneration.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Selective brain targeting with improved delivery methods may also shift the fate of the antibodies that have previously failed.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Several long-term prevention trials and dose-adjusted clinical trials of Aβ antibodies are still ongoing, and early results of these trials have suggested positive outcomes.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a></div><div class="NLM_p">Over the past decade, many protein aggregation inhibitors have been developed as a part of anti-amyloid strategies. While several small molecules have advanced to clinical trials,<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> benzofuran analogues have been extensively studied due to their high affinity and selectivity toward Aβ fibrils.<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14-16)</a> More importantly, as an alternative approach to currently developed AD therapies, recent studies have focused on multifunctional ligands and hybrid drugs.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21">(17-21)</a> These hybrid drugs combine inhibitors of cholinesterase or antioxidants with an antiaggregation inhibitor such as SKF-64346 (<b>1</b>).<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> While <b>1</b> is an excellent aggregation inhibitor, its in vivo activity and pharmacokinetic parameters have never been reported. We speculated that novel aggregation inhibitors may streamline the effort to develop highly effective therapeutic agents for AD treatment. Therefore, we investigated a diverse series of benzofuran analogues as Aβ aggregation inhibitors and discovered MDR-1339 (<b>8</b>), 2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)benzofuran, as a clinical candidate (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). In this work, we aimed to determine the antiamyloidogenic activity of <b>8</b> in vitro and in vivo and to assess its therapeutic effects in AD model mice. We evaluated the antiaggregation and disaggregation properties of <b>8</b> by using preformed aggregates and soluble Aβ oligomers. In addition, we examined the in vivo activity of <b>8</b> by performing cognitive functional assays and quantifying the amounts of Aβ in the brains of acute and transgenic AD model mice. The antiamyloidogenic activity of <b>8</b> was further verified by in-depth studies on pharmacokinetics and brain permeability.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. β-Amyloid aggregation inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11010" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11010" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">A highly efficient scale-up synthesis of <b>8</b> was accomplished in five steps (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The Wittig reaction of 3,4-(dimethoxybenzyl)triphenylphosphonium chloride <b>3</b> with available aldehyde <b>2</b>, the oxidative intramolecular cyclization<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> of 2-hydroxystilbene <b>4</b> to benzofuran <b>5</b>, the basic hydrolysis of ester <b>5</b>, the reduction of acid <b>6</b> with NaBH<sub>4</sub>, and the final methylation of <b>7</b> led to the production of target compound <b>8</b> with an overall yield of 45.4% and a purity >99%. This convenient and economical procedure is remarkably applicable for multikilogram-scale production.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Scale-Up Synthesis of <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DBU, CH<sub>3</sub>CN, rt, 3 h; (b) I<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, THF, reflux, 4 h; (c) LiOH, MeOH–H<sub>2</sub>O, 50 °C, 3 h; (d) (i) NaBH<sub>4</sub>, THF, reflux, 1 h, (ii) I<sub>2</sub>, THF, reflux, 4 h; (e) MeI, <i>t</i>-BuOK, THF, rt, 2 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> In Vitro Activity</h3><div class="NLM_p">To determine whether <b>8</b> can inhibit the aggregation of Aβ monomers, we incubated monomeric Aβ<sub>1–42</sub> solutions with <b>8</b> at different concentrations and we quantified the amount of Aβ aggregates by performing thioflavin T (ThT) assays. Because ThT generates fluorescent signals proportional to the amount of Aβ fibrils, we calculated the percentage of the ThT fluorescence of each sample based on the fluorescent signals of untreated controls. We also performed the assays by using quercetin (QC), a known aggregation inhibitor, as our positive control. As shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>a, <b>8</b> blocked the formation of Aβ aggregates in a dose-dependent manner, inhibiting the formation of Aβ fibrils up to 50% compared to the control. In addition, when we incubated <b>8</b> with solutions containing preformed Aβ aggregates, <b>8</b> appeared to disaggregate Aβ fibrils, reducing the amountof Aβ aggregates by 40% compared to that of the control (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b). On the basis of these observations, we believe that <b>8</b> not only blocked the formation of Aβ fibrils but also effectively disaggregated preformed Aβ aggregates. Aggregation of Aβ fibrils and disaggregation by <b>8</b> during the ThT assays was also confirmed by TEM images (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00844/suppl_file/jm7b00844_si_001.pdf" class="ext-link">Supporting Information, Figure S1</a>).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of <b>8</b> on (a) the aggregation of monomeric Aβ<sub>1–42</sub> and (b) the disaggregation of Aβ fibrils in vitro. ThT assays were performed by incubating 25 μM monomeric Aβ<sub>1–42</sub> solutions (a) or preformed Aβ aggregates (b) with <b>8</b> at the indicated concentrations. The data are presented as the mean ± SD from three independent experiments: one-way ANOVA, Dunnett test, (∗) <i>p</i> < 0.001 vs control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To investigate whether <b>8</b> can protect cells from Aβ-induced toxicity, we carried out cytotoxicity assays using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). We treated HT22 cells, a neuronal cell line derived from the mouse hippocampus, with <b>8</b> at different concentrations and subsequently incubated these cells with preformed Aβ aggregates. The cell viability of each sample was assessed by calculating percent values based on the changes of the signal intensity between untreated cells and Aβ-treated cells as a control. As shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a, the treatment of Aβ aggregates alone reduced the cell viability to 40% of that observed in normal cells.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Effect of <b>8</b> on the cell viability of the HT22 cells exposed to Aβ aggregates. (b) Effect of <b>8</b> on cell viability without the treatment of Aβ aggregates. HT22 cells were treated with preformed Aβ aggregates that were prepared by using 25 μM monomeric Aβ solutions. The data are presented as the mean ± SD from three independent experiments: one-way ANOVA, Dunnett test, (∗) <i>p</i> < 0.001 vs control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The treatment of <b>8</b> protected cells from this Aβ-induced toxicity in a dose-dependent manner, maintaining cell viability to normal levels at 10 μM. We also measured the cytotoxicity of <b>8</b> in HT22 cells without Aβ aggregates, confirming that <b>8</b> alone did not affect cell viability at the indicated concentrations (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b). These results suggest that <b>8</b> suppressed the formation of toxic Aβ aggregates, protecting cells from Aβ-induced toxicity.</div><div class="NLM_p">Next, we wanted to further verify that <b>8</b> can suppress the formation of Aβ aggregates. Therefore, we incubated Aβ aggregates with <b>8</b> and analyzed the size distribution using SDS–PAGE followed by silver staining. In addition, we also incubated Aβ aggregates with congo red, a diazo dye with antiamyloidogenic activity,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> as a positive control for comparison. As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, when we started the incubation, all samples contained a mixture of monomeric, dimeric, and trimeric Aβ peptides. After the samples were incubated for 48 h, we found that these monomeric peptides remained in congo red- and <b>8</b>-treated samples. On the other hand, these low molecular weight bands mostly disappeared in the vehicle-treated samples, implying that they transformed into high molecular aggregates. These results suggest that <b>8</b> prevented oligomer formation ofAβ peptides and reduced the formation of Aβ fibrils to a similar extent as congo red.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of <b>8</b> on preformed Aβ aggregates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> In Vivo Activity</h3><div class="NLM_p">To verify the antiamyloidogenic activity of <b>8</b>, we evaluated its efficacy in animal models of AD. First, we assessed learning and memory function in an acute AD mouse model by performing step-through passive avoidance tests. In this model, Aβ aggregates were directly injected into the brains of normal mice to induce acute neurotoxicity. After orally administering <b>8</b> for 3 consecutive days, the passive avoidance responses were evaluated by following the standard protocol.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a, vehicle-treated mice demonstrated significantly reduced step-through latency (sec) due to the acute impairment of cognitive function; however, the treatment of <b>8</b> effectively restored the passive avoidance responses in a dose-dependent manner, with an ED<sub>50</sub> of 0.19 mg/kg. Specifically, the step-through latency in the sessions with mice treated with a 10 mg/kg dose (201.2 ± 29.4) was restored close to the control level.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Behavioral effects of <b>8</b> in an acute AD model mice: (a) passive avoidance tests to assess learning and memory impairments; (b) Y maze tests to assess spatial memory function ((##) <i>P</i> < 0.01 vs control, (∗) <i>P</i> < 0.05, (∗∗) <i>P</i> < 0.01 vs vehicle).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition, we performed Y-maze tests to further verify the in vivo activity of <b>8</b>. As described in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b, vehicle-treated mice showed a significantly suppressed percentage of spontaneous alternation compared to that in normal mice, indicating severe impairments in spatial memory; however, the treatment of <b>8</b> again restored alternation behavior in a dose-dependent manner, with an ED<sub>50</sub> of 0.18 mg/kg. More importantly, <b>8</b> appeared to fully recover the percentage of alternation at a dose of 1 mg/kg (71.22 ± 3.14) and a dose of 10 mg/kg (73.07 ± 2.83).</div><div class="NLM_p">On the basis of these observations, we decided to test <b>8</b> with a double transgenic AD mouse model, APP/PS1. In APP/PS1 mice, extracellular Aβ deposition can be detected at the age of 2.5 months and apparent dysfunction of learning and memory can be monitored at the age of 6–8 months.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> While we observed the significant improvement in the Y-maze tests at the dose of 10 mg/kg in our acute AD model mice, we speculated that the double transgenic animal model might require much higher doses since they were in the further advanced state of AD. Therefore, we decided to treat 29-week-old APP/PS1 mice with <b>8</b> at doses of 30 and 100 mg/kg for 8 weeks by daily oral administration and performed Y-maze tests. As described in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>, vehicle-treated mice demonstrated a severe reduction in the percentage of spontaneous alternation (52.64 ± 4.15), which was even lower than the values observed for the acute AD model mice; however, the treatment with <b>8</b> significantly improved spontaneous alternation at both doses without any apparent toxicity: 63.73 ± 1.06% for 30 mg/kg and 63.93 ± 2.24% for 100 mg/kg.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Y-maze tests following <b>8</b> treatment in APP/PS1 mice: (∗) <i>P</i> < 0.05, (∗∗) <i>P</i> < 0.01 vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To confirm whether the antiamyloidogenic activity of <b>8</b> resulted in these improvements in cognitive function in APP/PS1 mice, we quantified the levels of Aβ aggregates in the brain by immunoassay. As demonstrated in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>, when compared to the vehicle-treated mice, mice treated with <b>8</b> appeared to have dose-dependent reductions in the amounts of Aβ<sub>1–40</sub> and Aβ<sub>1–42</sub>, while mice treated with 100 mg/kg had the most significant reductionof Aβ<sub>1–42</sub> (70% of vehicle group). We believe that these results support that <b>8</b> effectively reduced the overall amount of Aβ aggregates, thus improving cognitive function in AD model mice.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) Aβ<sub>1–40</sub> and (b) Aβ<sub>1–42</sub> levels in the brains of APP/PS1 transgenic mice treated with <b>8</b>: (∗∗) <i>P</i> < 0.01 vs vehicle. The brain Aβ levels were quantified by using the antibodies specific to monomeric Aβ, after brain tissues were homogenized and amyloid fibrils were solubilized to monomers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Pharmacokinetics and Brain Permeability</h3><div class="NLM_p">To further validate the in vivo activity of <b>8</b>, we determined pharmacokinetic parameters and summarized these values in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. The bioavailability of <b>8</b> increased up to 79.1% (30 mg/kg) in a dose-dependent manner, indicating that our compound is systematically well absorbed and suitable for oral administration in mice (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). When we administered <b>8</b> to various other species, we also observed high bioavailabilities and a relatively long half-life among rats and monkeys, which is consistent with the results from ICR mice (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Pharmacokinetic Parameters of <b>8</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">iv</th><th class="rowsep1 colsep0" colspan="3" align="center">oral</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PK parameter</th><th class="colsep0 rowsep0" align="center">3 mg/kg</th><th class="colsep0 rowsep0" align="center">3 mg/kg</th><th class="colsep0 rowsep0" align="center">10 mg/kg</th><th class="colsep0 rowsep0" align="center">30 mg/kg</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub></td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">4869.9 (<i>C</i><sub>0</sub>)</td><td class="colsep0 rowsep0" align="left">101.9</td><td class="colsep0 rowsep0" align="left">660.1</td><td class="colsep0 rowsep0" align="left">1700.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>last</sub></td><td class="colsep0 rowsep0" align="left">1303.5</td><td class="colsep0 rowsep0" align="left">245.6</td><td class="colsep0 rowsep0" align="left">2238.8</td><td class="colsep0 rowsep0" align="left">10429.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>inf</sub></td><td class="colsep0 rowsep0" align="left">1325.1</td><td class="colsep0 rowsep0" align="left">283.1</td><td class="colsep0 rowsep0" align="left">2293.8</td><td class="colsep0 rowsep0" align="left">10475.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BA</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">21.4</td><td class="colsep0 rowsep0" align="left">51.9</td><td class="colsep0 rowsep0" align="left">79.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">AUC<sub>inf</sub>, total area under the plasma concentration–time curve from time zero to time infinity (h·ng/mL); AUC<sub>last</sub>, total area under the plasma concentration–time curve from time zero to the last measured time (h·ng/mL); <i>C</i><sub>max</sub>, peak plasma concentration (ng/mL); <i>T</i><sub>1/2</sub>, terminal half-life (h); <i>T</i><sub>max</sub>, time to reach <i>C</i><sub>max</sub> (h); BA, bioavailability (%).</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacokinetic Parameters of <b>8</b> in Rat, Dog, Monkey, and Mouse<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">iv</th><th class="rowsep1 colsep0" colspan="6" align="center">oral</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">Cl</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub></th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center">AUC</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub></th><th class="colsep0 rowsep0" align="center"><i>F</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left">421</td><td class="colsep0 rowsep0" align="left">4203</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">1607</td><td class="colsep0 rowsep0" align="left">4186</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">12.9</td><td class="colsep0 rowsep0" align="left">969</td><td class="colsep0 rowsep0" align="left">13747</td><td class="colsep0 rowsep0" align="left">12.9</td><td class="colsep0 rowsep0" align="left">70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">10.5</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">2.75</td><td class="colsep0 rowsep0" align="left">944</td><td class="colsep0 rowsep0" align="left">13178</td><td class="colsep0 rowsep0" align="left">5.87</td><td class="colsep0 rowsep0" align="left">83.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">AUC, area under curve (ng·h/mL); <i>C</i><sub>max</sub>, maximum concentration (ng/mL); <i>T</i><sub>1/2</sub>, half-life (h); <i>T</i><sub>max</sub>, time to reach <i>C</i><sub>max</sub>; CL, time-averaged total body clearance (mL min<sup>–1</sup> kg<sup>–1</sup>); <i>V</i><sub>ss</sub>, apparent volume of distribution at steady state (L/kg); <i>F</i>, bioavailability (%).</p></div></div></div><div class="NLM_p">After confirming the high bioavailability of <b>8</b>, we evaluated the blood–brain barrier (BBB) permeability of <b>8</b> by oral administration in ICR mice over the course of 9 h. As shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>, <b>8</b> demonstrated consistent brain to plasma ratios (<i>K</i><sub>p</sub>) that ranged from 1.2 to 1.5, indicating that <b>8</b> efficiently crossed the BBB. This high bioavailability and BBB permeability again support our hypothesis that <b>8</b> effectively reduced Aβ aggregates in the brains of AD mice and restored their cognitive function.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Blood–brain barrier permeability of <b>8</b>. ICR mice (<i>n</i> = 3) were orally administered 10 mg/kg of <b>8</b>. <i>K</i><sub>p</sub> indicates AUC<sub>brain</sub>/AUC<sub>plasma</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Cytochrome P450 (CYP) Inhibition</h3><div class="NLM_p">To evaluate the toxicity profile of <b>8</b>, we determined the inhibition of cytochrome P450 using the human liver microsome. As shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, <b>8</b> did not significantly inhibit a panel of CYP isozymes, while it slightly inhibited CYP2C8 (IC<sub>50</sub> = 31.4 μM). This result suggests that <b>8</b> is unlikely to cause drug–drug interactions via metabolism.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Human CYP Inhibition of <b>8</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="7" align="center">CYP450</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">1A2</th><th class="colsep0 rowsep0" align="center">2A6</th><th class="colsep0 rowsep0" align="center">2C8</th><th class="colsep0 rowsep0" align="center">2C9</th><th class="colsep0 rowsep0" align="center">2C19</th><th class="colsep0 rowsep0" align="center">2D6</th><th class="colsep0 rowsep0" align="center">3A4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">31.4</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr></tbody></table></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this work, we developed an orally active and BBB-permeable Aβ aggregation inhibitor as a potential therapeutic option for Alzheimer’s disease. Compound <b>8</b> demonstrated antiamyloidogenic activity against preformed Aβ aggregates and soluble oligomers in vitro. Compound <b>1</b> also protected neuronal cells from Aβ-induced cytotoxicity in a dose-dependent manner. To further validate the antiamyloidogenic activity, <b>8</b> was orally administered to AD model mice, and it restored learning and memory function to a level close to that of the control without any apparent toxicity. When we examined the amounts of brain Aβ aggregates in these AD mice, <b>8</b> significantly reduced the amount of Aβ<sub>1–42</sub> aggregates, suggesting that the antiamyloidogenic activity of <b>8</b> improved the cognitive function of AD model mice. In addition, pharmacokinetic parameters indicated that <b>8</b> has high oral bioavailability in mice, rats, and monkeys and also showed consistently high brain to plasma ratios (<i>K</i><sub>p</sub>) over 9 h. Taken together, these results suggest that <b>8</b> is a highly effective Aβ aggregation inhibitor with excellent bioavailability and brain permeability, and it is currently under clinical development. We believe that in ongoing clinical phase I study, <b>8</b> will provide a novel scaffold for an Aβ aggregation inhibitor that may offer a promising alternative treatment for AD in the near future.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08584" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08584" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Methods</h3><div class="NLM_p last"><sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker Analytik, DE/AVANCE Digital 500 at 500 and 125 MHz. Mass spectra were recorded on a VG Trio-2 GC–MS instrument and a 6460 triple quad LC–MS instrument. All final compounds were purified to >95% purity, as determined by high-performance liquid chromatography (HPLC). HPLC was performed on an Agilent 1120 compact LC (G4288A) instrument using an Agilent TC-C18 column (4.6 mm × 250 mm, 5 μm).</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Methyl 3-(3-(3,4-dimethoxystyryl)-4-hydroxyphenyl)propanoate (<b>4</b>)</h3><div class="NLM_p last">3,4-Dimethoxybenzyl chloride (155.8 kg), triphenylphosphine (203.8 kg), and sodium iodide (89.6 kg) were placed in the first reactor, and then acetonitrile (655 L) was added. The resulting mixture was heated to reflux at 75–85 °C for 2 h to terminate the reaction. The reaction solution was cooled to ambient temperature. Then, methyl 3-(3-formyl-4-hydroxyphenyl)propanoate (<b>2</b>) (131 kg) was placed in a second reactor, and acetonitrile (655 L) was added. The resulting mixture was stirred at room temperature, and then, 1,8-diazabicyclo[5.4.0]-7-undecene (DBU, 114.9 kg) was added. Next, the (3,4-dimethoxybenzyl)triphenylphosphonium chloride (<b>3</b>) prepared in the first reactor was added dropwise into the second reactor for 30 min. After 3 h, the reaction was terminated. The reaction solution was cooled to room temperature and concentrated under reduced pressure. The concentrate was dissolved in ethyl acetate (1400 L) and stirred with the addition of water (1270 L). The organic layer was separated, dehydrated with MgSO<sub>4</sub> (40 kg), and concentrated under reduced pressure. The concentrate was cooled to room temperature, dissolved in ethyl acetate (400 L), and crystallized by adding <i>n</i>-hexane (400 L). Stirring was performed at room temperature for 2 h, and the crystals were filtered, washed with ethyl acetate/<i>n</i>-hexane = 1/3 (65.5 L), and dried in a vacuum at 40 °C, yielding <b>4</b> (326.6 kg, 75.8% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 7.39 (s, 1H), 7.32–6.85 (m, 5H), 6.78 (d, 1H, <i>J</i> = 8.20 Hz), 3.98 (s, 3H), 3.94 (s, 3H), 3.72 (s, 3H), 2.95 (t, 2H, <i>J</i> = 7.40 Hz), 2.68 (t, 2H, <i>J</i> = 8.00 Hz).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Methyl 3-(2-(3,4-Dimethoxyphenyl)benzofuran-5-yl)propanoate (<b>5</b>)</h3><div class="NLM_p last">Iodine (359.7 kg) was added to <b>4</b> (323.5 kg) in THF (1600 L), and K<sub>2</sub>CO<sub>3</sub> (391.7 kg) was added. The mixture was refluxed. After 4 h, the mixture was concentrated in vacuo and dissolved in ethyl acetate (1600 L). A saturated Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution (Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> 140 kg/water 1000 L) was added to the mixture and stirred for 10 min. The organic compound was extracted with ethyl acetate and dried over MgSO<sub>4</sub> (40 kg) and concentrated in vacuo (40–50 °C). The concentrate was dissolved in dichloromethane (300 L) and crystallized by adding MeOH (300 L). Stirring was performed at room temperature for 2 h, and the crystals were filtered, washed with MeOH (32 L), and dried at 40 °C over 12 h, yielding <b>5</b> (125.4 kg, 78% yield, >95% purity). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 7.48–7.43 (m, 4H), 7.13 (dd, 1H, <i>J</i> = 8.40 Hz, 2.10 Hz), 6.97 (d, 1H, <i>J</i> = 8.40 Hz), 6.89 (s, 1H), 4.30 (s, 3H), 3.97 (s, 3H), 3.73 (s, 3H), 3.09 (t, 2H, <i>J</i> = 7.60 Hz), 2.73 (t, 2H, <i>J</i> = 7.70 Hz).</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 3-(2-(3,4-Dimethoxyphenyl)benzofuran-5-yl)propanoic Acid (<b>6</b>)</h3><div class="NLM_p last">LiOH·H<sub>2</sub>O (13.6 kg) was dissolved in water (385 L), and it was added to compound <b>5</b> (55 kg) in MeOH (440 L) and refluxed for 3 h. The mixture was allowed to cooled to ambient temperature, acidified to pH 2.0–3.0 with 6 N HCl. The solution was stirred at room temperature for 30 min and at 0–5 °C for 1 h. Crystallized product was filtered, washed with water (55 L), and dried at 60 °C over 24 h, yielding <b>6</b> (52.2 kg, 99% yield, >99% purity). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 12.03 (s, 1H), 7.49–7.40 (m, 4H), 7.15 (dd, 1H, <i>J</i> = 8.30 Hz, 2.00 Hz), 6.98 (d, 1H, 8.30 Hz), 6.89 (s, 1H), 4.30 (s, 3H), 4.00 (s, 3H), 3.10 (t, 2H, <i>J</i> = 7.70 Hz), 2.78 (t, 2H, <i>J</i> = 8.10 Hz).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 3-(2-(3,4-Dimethoxyphenyl)benzofuran-5-yl)propan-1-ol (<b>7</b>)</h3><div class="NLM_p last">NaBH<sub>4</sub> (12.1 kg) and THF (364 L) were placed in a reactor and stirred. <b>6</b> (52 kg) was slowly added (generation of H<sub>2</sub> gas) to the mixture. THF (26 L) was added, and the resulting mixture was heated to reflux at 65–75 °C for 1 h. The reaction solution was cooled to 30–40 °C, and I<sub>2</sub> (28.3 kg) and THF (26 L) were added. The reaction solution was heated to reflux to 65–75 °C for 4 h, and the reaction was terminated. The reaction solution was cooled to 10–15 °C, and ethyl acetate (364 L) was added. Water (364 L) was added while paying attention to gas generation. The pH of the solution was adjusted to 3.0–4.0 using 6 N HCl. The layers were separated; the organic layer was stored, and ethyl acetate (104 L) was added to the water layer. After layer separation, the water layer was discarded, and the organic layer was combined with the stored organic layer. The organic layer was washed with 10% NaHSO<sub>3</sub> (NaHSO<sub>3</sub> 36.4 kg/water 364 L), dehydrated with MgSO<sub>4</sub> (26 kg), and washed with ethyl acetate (52 L). The reaction solution was concentrated under reduced pressure at 40–50 °C, and isopropyl alcohol (260 L) was added to the concentrate, heated to 70–80 °C, and dissolved. Next, the concentrate was slowly cooled to 20–25 °C, thus producing crystals. Stirring was performed at 20–25 °C for 2 h, and the crystals were filtered, washed with 52 L of isopropyl alcohol, and dried at 40 °C for 12 h or longer, yielding <b>7</b> (42 kg, 84.3% yield, >99% purity). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 7.48–7.40 (m, 4H), 7.10 (dd, 1H, <i>J</i> = 8.40 Hz, 2.10 Hz), 6.96 (d, 1H, <i>J</i> = 8.40 Hz), 6.85 (s, 1H),4.30 (s, 3H), 4.00 (s, 3H), 3.74 (t, 2H, <i>J</i> = 6.40 Hz), 2.84 (t, 2H, <i>J</i> = 7.30 Hz), 1.99 (q, 2H, <i>J</i> = 6.40 Hz), 1.71 (s, 1H).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-(3,4-Dimethoxyphenyl)-5-(3-methoxypropyl)benzofuran (<b>8</b>)</h3><div class="NLM_p last"><i>t</i>-BuOK (76.3 kg) and THF (594 L) were placed in a reactor and stirred. <b>7</b> (84.9 kg) was added, and then THF (84.9 L) was added. The resulting solution was cooled to 10–15 °C, and MeI (50.8 L) was added at 30 °C or less. The solution was stirred at 20–25 °C for 2 h, and the reaction was subsequently terminated. The solution was cooled to 10–15 °C, and ethyl acetate (594 L) was added. Water (594 L) was added while paying attention to gas generation. The pH of the solution was adjusted to 3.0–4.0 using 6 N HCl. After layer separation, the organic layer was stored, and ethyl acetate (170 L) was added to the water layer. After a subsequent layer separation, the water layer was discarded, and the organic layer was combined with the stored organic layer. The organic layer was washed with 10% NaHSO<sub>3</sub> (NaHSO<sub>3</sub> 59.4 kg/water 594 L), dehydrated with MgSO<sub>4</sub> (42.5 kg), and washed with ethyl acetate (84.9 L). The reaction solution was concentrated under reduced pressure at 40–50 °C. EtOH (424.5 L) was added to the concentrate. The concentrate was heated to 70–80 °C and dissolved. Next, the concentrate was slowly cooled to 20–25 °C, thus producing crystals. Stirring was performed at 20–25 °C for 2 h, and the crystals were filtered, washed with EtOH (84.9 L), and dried at 40 °C for 8 h or longer, yielding <b>8</b> (81.7 kg, 92.1% yield, >99% purity) as a white solid. Mp = 101–105 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 7.48–7.32 (m, 4H), 7.09 (d, 1H, <i>J</i> = 8.50 Hz), 6.94 (d, 1H, <i>J</i> = 8.00 Hz), 6.85 (s, 1H), 3.99 (s, 3H), 3.93 (s, 3H), 3.41 (t, 2H, <i>J</i> = 5.50 Hz), 3.36 (s, 3H), 2.78 (t, 2H, <i>J</i> = 7.50 Hz), 1.94 (t, 2H, <i>J</i> = 7.00 Hz). <sup>13</sup>C NMR (200 MHz, CDCl<sub>3</sub>) δ 156.1, 153.3, 149.4, 149.1, 136.5, 129.5, 124.5, 123.6, 119.9, 117.8, 111.3, 110.6, 108.0, 99.8, 71.9, 58.5, 55.9, 32.2, 22.6, 14.1. MS(FAB) <i>m</i>/<i>z</i> 327 [M + H]<sup>+</sup>. HRMS(FAB) calcd for C<sub>20</sub>H<sub>22</sub>O<sub>4</sub> [M + H]<sup>+</sup> 327.1591, found 327.1594.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00844">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00844" class="ext-link">10.1021/acs.jmedchem.7b00844</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Detailed experimental procedures for in vitro assays and in vivo animal studies (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00844/suppl_file/jm7b00844_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00844/suppl_file/jm7b00844_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00844/suppl_file/jm7b00844_si_001.pdf">jm7b00844_si_001.pdf (220.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00844/suppl_file/jm7b00844_si_002.csv">jm7b00844_si_002.csv (0.34 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00844" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53350" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53350" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeewoo Lee</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic
of Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7832-6719" title="Orcid link">http://orcid.org/0000-0002-7832-6719</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5d3738382a32321d2e3328733c3e73362f"><span class="__cf_email__" data-cfemail="7a101f1f0d15153a09140f541b19541108">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hee-Jin Ha</span> - <span class="hlFld-Affiliation affiliation">Medifron
DBT, Sandanro 349, Danwon-gu, Ansan-si, Gyeonggi-do 15426, Republic of Korea</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro,
Jangan-gu, Suwon, Gyeonggi-do 16419, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dong Wook Kang</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic
of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyuk-Min Kim</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic
of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jin-Mi Kang</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic
of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jihyae Ann</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic
of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyae Jung Hyun</span> - <span class="hlFld-Affiliation affiliation">Daewoong
Pharmaceutical, 72 Dugye-ro, Pogok-eup, Cheoin-gu, Yongin-si, Gyeonggi-do 17028, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joon Hwan Lee</span> - <span class="hlFld-Affiliation affiliation">Daewoong
Pharmaceutical, 72 Dugye-ro, Pogok-eup, Cheoin-gu, Yongin-si, Gyeonggi-do 17028, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sae Hee Kim</span> - <span class="hlFld-Affiliation affiliation">Daewoong
Pharmaceutical, 72 Dugye-ro, Pogok-eup, Cheoin-gu, Yongin-si, Gyeonggi-do 17028, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hee Kim</span> - <span class="hlFld-Affiliation affiliation">Medifron
DBT, Sandanro 349, Danwon-gu, Ansan-si, Gyeonggi-do 15426, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kwanghyun Choi</span> - <span class="hlFld-Affiliation affiliation">Medifron
DBT, Sandanro 349, Danwon-gu, Ansan-si, Gyeonggi-do 15426, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyun-Seok Hong</span> - <span class="hlFld-Affiliation affiliation">Medifron
DBT, Sandanro 349, Danwon-gu, Ansan-si, Gyeonggi-do 15426, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">YoungHo Kim</span> - <span class="hlFld-Affiliation affiliation">Medifron
DBT, Sandanro 349, Danwon-gu, Ansan-si, Gyeonggi-do 15426, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dong-Gyu Jo</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro,
Jangan-gu, Suwon, Gyeonggi-do 16419, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiyoun Lee</span> - <span class="hlFld-Affiliation affiliation">Department
of Global Medical Science, Sungshin University, 76 Dobong-ro, Gangbuk-gu, Seoul 01133, Republic
of Korea</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d105e1733-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24033" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24033" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported by Grant HI11C0918 of the Korea Technology R&D Project, Ministry of Health & Welfare, Republic of Korea, and partly by Cooperative Research Program for Agriculture Science & Technology Development (Grant PJ00910303) by RDA.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i22" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i22"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i23" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i23"> Abbreviations Used</h2><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ThT</td><td class="NLM_def"><p class="first last">thioflavin T</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">SDS–PAGE</td><td class="NLM_def"><p class="first last">sodium dodecyl sulfate–polyacrylamide gel electrophoresis</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 27 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Knowles, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendruscolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, C. M.</span><span> </span><span class="NLM_article-title">The amyloid state and its association with protein misfolding diseases</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span><span class="refDoi"> DOI: 10.1038/nrm3810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1038%2Fnrm3810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=24854788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosV2lurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=384-396&author=T.+P.+Knowlesauthor=M.+Vendruscoloauthor=C.+M.+Dobson&title=The+amyloid+state+and+its+association+with+protein+misfolding+diseases&doi=10.1038%2Fnrm3810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid state and its association with protein misfolding diseases</span></div><div class="casAuthors">Knowles, Tuomas P. J.; Vendruscolo, Michele; Dobson, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">384-396</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phenomenon of protein aggregation and amyloid formation has become the subject of rapidly increasing research activities across a wide range of scientific disciplines.  Such activities have been stimulated by the assocn. of amyloid deposition with a range of debilitating medical disorders, from Alzheimer's disease to type II diabetes, many of which are major threats to human health and welfare in the modern world.  It has become clear, however, that the ability to form the amyloid state is more general than previously imagined, and that its study can provide unique insights into the nature of the functional forms of peptides and proteins, as well as understanding the means by which protein homeostasis can be maintained and protein metastasis avoided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryuIN_Qt8Fa7Vg90H21EOLACvtfcHk0lgrAh6Fj6gmoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosV2lurk%253D&md5=68e2e4d963646f1daca50ab3288f5a37</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm3810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3810%26sid%3Dliteratum%253Aachs%26aulast%3DKnowles%26aufirst%3DT.%2BP.%26aulast%3DVendruscolo%26aufirst%3DM.%26aulast%3DDobson%26aufirst%3DC.%2BM.%26atitle%3DThe%2520amyloid%2520state%2520and%2520its%2520association%2520with%2520protein%2520misfolding%2520diseases%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D384%26epage%3D396%26doi%3D10.1038%2Fnrm3810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+Progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lgrAh6Fj6gmoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Berk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, M. N.</span><span> </span><span class="NLM_article-title">Successes and failures for drugs in late-stage development for Alzheimer’s disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">792</span><span class="refDoi"> DOI: 10.1007/s40266-013-0108-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1007%2Fs40266-013-0108-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=23943247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=783-792&author=C.+Berkauthor=M.+N.+Sabbagh&title=Successes+and+failures+for+drugs+in+late-stage+development+for+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs40266-013-0108-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Successes and Failures for Drugs in Late-Stage Development for Alzheimer's Disease</span></div><div class="casAuthors">Berk, Camryn; Sabbagh, Marwan N.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">783-792</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  To date, symptomatic medications prevail as the mainstay of treatment options for Alzheimer's disease (AD).  There have been tremendous investments made to increase the nos. of drugs approved and the targets engaged, in an effort to alter the disease course or pathophysiol. of AD.  Unfortunately, almost all studies have not met expectations and no new drug (beyond medical foods) has been approved for the treatment of AD in the last decade.  This review is a comparison of novel AD therapies in the late phases of clin. testing, including recent high-profile clin. failures, and agents in development with relatively unexplored mechanisms of action, with a focus on their potential as therapeutic agents and their proposed advantages over the treatments currently in use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru8C4Zf__NMrVg90H21EOLACvtfcHk0lgPfv3TxPbvyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bM&md5=92a0562710d6e1e36ce087d1457a936c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs40266-013-0108-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-013-0108-6%26sid%3Dliteratum%253Aachs%26aulast%3DBerk%26aufirst%3DC.%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26atitle%3DSuccesses%2520and%2520failures%2520for%2520drugs%2520in%2520late-stage%2520development%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDrugs%2520Aging%26date%3D2013%26volume%3D30%26spage%3D783%26epage%3D792%26doi%3D10.1007%2Fs40266-013-0108-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Lessons from a failed gamma-secretase alzheimer trial</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1016/j.cell.2014.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1016%2Fj.cell.2014.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=25417150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2msrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2014&pages=721-726&author=B.+De+Strooper&title=Lessons+from+a+failed+gamma-secretase+alzheimer+trial&doi=10.1016%2Fj.cell.2014.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from a Failed γ-Secretase Alzheimer Trial</span></div><div class="casAuthors">De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">721-726</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  γ-Secretase proteases have been assocd. with pathol. in Alzheimer disease (AD), but we are just beginning to understand their basic mechanisms and physiol. roles.  A neg. drug trial with a broad spectrum γ-secretase inhibitor in AD patients has severely dampened enthusiasm for the potential of pursuing γ-secretase research therapeutically.  This pessimism is unwarranted: anal. of available information presented here demonstrates significant confounds for interpreting the outcome of the trial and argues that the major lessons pertain to broad knowledge gaps that are imperative to fill.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoltWoN44tWybVg90H21EOLACvtfcHk0lgPfv3TxPbvyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2msrnI&md5=9d19644a7135552c6c4ef2b812b4b665</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DLessons%2520from%2520a%2520failed%2520gamma-secretase%2520alzheimer%2520trial%26jtitle%3DCell%26date%3D2014%26volume%3D159%26spage%3D721%26epage%3D726%26doi%3D10.1016%2Fj.cell.2014.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Yu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span> </span><span class="NLM_article-title">Developing therapeutic antibodies for neurodegenerative disease</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span><span class="refDoi"> DOI: 10.1007/s13311-013-0187-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1007%2Fs13311-013-0187-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=459-472&author=Y.+J.+Yuauthor=R.+J.+Watts&title=Developing+therapeutic+antibodies+for+neurodegenerative+disease&doi=10.1007%2Fs13311-013-0187-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs13311-013-0187-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-013-0187-4%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%2BJ.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26atitle%3DDeveloping%2520therapeutic%2520antibodies%2520for%2520neurodegenerative%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2013%26volume%3D10%26spage%3D459%26epage%3D472%26doi%3D10.1007%2Fs13311-013-0187-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Mullard, A.</span><span> </span><span class="NLM_article-title">Alzheimer amyloid hypothesis lives on</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span><span class="refDoi"> DOI: 10.1038/nrd.2016.281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1038%2Fnrd.2016.281" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=3-5&author=A.+Mullard&title=Alzheimer+amyloid+hypothesis+lives+on&doi=10.1038%2Fnrd.2016.281"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.281%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DAlzheimer%2520amyloid%2520hypothesis%2520lives%2520on%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D16%26spage%3D3%26epage%3D5%26doi%3D10.1038%2Fnrd.2016.281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Saraiva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Praca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardino, L.</span><span> </span><span class="NLM_article-title">Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">235</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><span class="refDoi"> DOI: 10.1016/j.jconrel.2016.05.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1016%2Fj.jconrel.2016.05.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=27208862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC28XovV2hsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=2016&pages=34-47&author=C.+Saraivaauthor=C.+Pracaauthor=R.+Ferreiraauthor=T.+Santosauthor=L.+Ferreiraauthor=L.+Bernardino&title=Nanoparticle-mediated+brain+drug+delivery%3A+Overcoming+blood-brain+barrier+to+treat+neurodegenerative+diseases&doi=10.1016%2Fj.jconrel.2016.05.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases</span></div><div class="casAuthors">Saraiva, Claudia; Praca, Catarina; Ferreira, Raquel; Santos, Tiago; Ferreira, Lino; Bernardino, Liliana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-47</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) is a vital boundary between neural tissue and circulating blood.  The BBB's unique and protective features control brain homeostasis as well as ion and mol. movement.  Failure in maintaining any of these components results in the breakdown of this specialized multicellular structure and consequently promotes neuro inflammation and neurodegeneration.  In several high incidence pathologies such as stroke, Alzheimer's (AD) and Parkinson's disease (PD) the BBB is impaired.  However, even a damaged and more permeable BBB can pose serious challenges to drug delivery into the brain.  The use of nanoparticle (NP) formulations able to encapsulate mols. with therapeutic value, while targeting specific transport processes in the brain vasculature, may enhance drug transport through the BBB in neurodegenerative/ischemic disorders and target relevant regions in the brain for regenerative processes.  In this review, we will discuss BBB compn. and characteristics and how these features are altered in pathol., namely in stroke, AD and PD.  Addnl., factors influencing an efficient i.v. delivery of polymeric and inorg. NPs into the brain as well as NP-related delivery systems with the most promising functional outcomes will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaTfl3mFXDRLVg90H21EOLACvtfcHk0liniawJkakCWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XovV2hsbY%253D&md5=9a656f4dfad25bb41b0d8e4996822031</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2016.05.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2016.05.044%26sid%3Dliteratum%253Aachs%26aulast%3DSaraiva%26aufirst%3DC.%26aulast%3DPraca%26aufirst%3DC.%26aulast%3DFerreira%26aufirst%3DR.%26aulast%3DSantos%26aufirst%3DT.%26aulast%3DFerreira%26aufirst%3DL.%26aulast%3DBernardino%26aufirst%3DL.%26atitle%3DNanoparticle-mediated%2520brain%2520drug%2520delivery%253A%2520Overcoming%2520blood-brain%2520barrier%2520to%2520treat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2016%26volume%3D235%26spage%3D34%26epage%3D47%26doi%3D10.1016%2Fj.jconrel.2016.05.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Neves, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aires-da-Silva, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corte-Real, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanho, M. A.</span><span> </span><span class="NLM_article-title">Antibody approaches to treat brain diseases</span> <span class="citation_source-journal">Trends Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span><span class="refDoi"> DOI: 10.1016/j.tibtech.2015.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1016%2Fj.tibtech.2015.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslyrt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=36-48&author=V.+Nevesauthor=F.+Aires-da-Silvaauthor=S.+Corte-Realauthor=M.+A.+Castanho&title=Antibody+approaches+to+treat+brain+diseases&doi=10.1016%2Fj.tibtech.2015.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody Approaches To Treat Brain Diseases</span></div><div class="casAuthors">Neves, Vera; Aires-da-Silva, Frederico; Corte-Real, Sofia; Castanho, Miguel A. R. B.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biotechnology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-48</span>CODEN:
                <span class="NLM_cas:coden">TRBIDM</span>;
        ISSN:<span class="NLM_cas:issn">0167-7799</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Recombinant antibodies are an emerging class of therapeutics with substantial promise to treat central nervous system (CNS) diseases such as Alzheimer's, Parkinson's, stroke, and brain cancers.  However, poor blood-brain barrier (BBB) permeability hinders the progress of antibody therapies for conditions in which the target is located in the brain.  Nonetheless, antibodies can nowadays be engineered to enhance their therapeutic applications and translocation of the BBB using the natural portals of the brain.  This paper reviews advances in the development and engineering of therapeutic BBB-crossing antibodies and their high potential for treatment of CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLNJVWm-r4LVg90H21EOLACvtfcHk0liniawJkakCWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslyrt7vJ&md5=7d61a17720858884f59dd180ba6d9f54</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.tibtech.2015.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibtech.2015.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DNeves%26aufirst%3DV.%26aulast%3DAires-da-Silva%26aufirst%3DF.%26aulast%3DCorte-Real%26aufirst%3DS.%26aulast%3DCastanho%26aufirst%3DM.%2BA.%26atitle%3DAntibody%2520approaches%2520to%2520treat%2520brain%2520diseases%26jtitle%3DTrends%2520Biotechnol.%26date%3D2016%26volume%3D34%26spage%3D36%26epage%3D48%26doi%3D10.1016%2Fj.tibtech.2015.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Mullard, A.</span><span> </span><span class="NLM_article-title">Sting of Alzheimer’s failures offset by upcoming prevention trials</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span><span class="refDoi"> DOI: 10.1038/nrd3842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1038%2Fnrd3842" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=657-660&author=A.+Mullard&title=Sting+of+Alzheimer%E2%80%99s+failures+offset+by+upcoming+prevention+trials&doi=10.1038%2Fnrd3842"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd3842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3842%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DSting%2520of%2520Alzheimer%25E2%2580%2599s%2520failures%2520offset%2520by%2520upcoming%2520prevention%2520trials%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D657%26epage%3D660%26doi%3D10.1038%2Fnrd3842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Reardon, S.</span><span> </span><span class="NLM_article-title">Antibody drugs for Alzheimer’s show glimmers of promise</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">523</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">510</span><span class="refDoi"> DOI: 10.1038/nature.2015.18031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1038%2Fnature.2015.18031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=523&publication_year=2015&pages=509-510&author=S.+Reardon&title=Antibody+drugs+for+Alzheimer%E2%80%99s+show+glimmers+of+promise&doi=10.1038%2Fnature.2015.18031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature.2015.18031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature.2015.18031%26sid%3Dliteratum%253Aachs%26aulast%3DReardon%26aufirst%3DS.%26atitle%3DAntibody%2520drugs%2520for%2520Alzheimer%25E2%2580%2599s%2520show%2520glimmers%2520of%2520promise%26jtitle%3DNature%26date%3D2015%26volume%3D523%26spage%3D509%26epage%3D510%26doi%3D10.1038%2Fnature.2015.18031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sevigny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunstan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Gorman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arastu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollate, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintero-Monzon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikulskis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitsch, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandrock, A.</span><span> </span><span class="NLM_article-title">The antibody aducanumab reduces abeta plaques in Alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">537</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1038/nature19323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1038%2Fnature19323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=27582220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCqur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=537&publication_year=2016&pages=50-56&author=J.+Sevignyauthor=P.+Chiaoauthor=T.+Bussiereauthor=P.+H.+Weinrebauthor=L.+Williamsauthor=M.+Maierauthor=R.+Dunstanauthor=S.+Sallowayauthor=T.+Chenauthor=Y.+Lingauthor=J.+O%E2%80%99Gormanauthor=F.+Qianauthor=M.+Arastuauthor=M.+Liauthor=S.+Chollateauthor=M.+S.+Brennanauthor=O.+Quintero-Monzonauthor=R.+H.+Scannevinauthor=H.+M.+Arnoldauthor=T.+Engberauthor=K.+Rhodesauthor=J.+Ferreroauthor=Y.+Hangauthor=A.+Mikulskisauthor=J.+Grimmauthor=C.+Hockauthor=R.+M.+Nitschauthor=A.+Sandrock&title=The+antibody+aducanumab+reduces+abeta+plaques+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnature19323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The antibody aducanumab reduces Aβ plaques in Alzheimer's disease</span></div><div class="casAuthors">Sevigny, Jeff; Chiao, Ping; Bussiere, Thierry; Weinreb, Paul H.; Williams, Leslie; Maier, Marcel; Dunstan, Robert; Salloway, Stephen; Chen, Tianle; Ling, Yan; O'Gorman, John; Qian, Fang; Arastu, Mahin; Li, Mingwei; Chollate, Sowmya; Brennan, Melanie S.; Quintero-Monzon, Omar; Scannevin, Robert H.; Arnold, H. Moore; Engber, Thomas; Rhodes, Kenneth; Ferrero, James; Hang, Yaming; Mikulskis, Alvydas; Grimm, Jan; Hock, Christoph; Nitsch, Roger M.; Sandrock, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">537</span>
        (<span class="NLM_cas:issue">7618</span>),
    <span class="NLM_cas:pages">50-56</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles in the brain, accompanied by synaptic dysfunction and neurodegeneration.  Antibody-based immunotherapy against Aβ to trigger its clearance or mitigate its neurotoxicity has so far been unsuccessful.  Here we report the generation of aducanumab, a human monoclonal antibody that selectively targets aggregated Aβ.  In a transgenic mouse model of AD, aducanumab is shown to enter the brain, bind parenchymal Aβ, and reduce sol. and insol. Aβ in a dose-dependent manner.  In patients with prodromal or mild AD, one year of monthly i.v. infusions of aducanumab reduces brain Aβ in a dose- and time-dependent manner.  This is accompanied by a slowing of clin. decline measured by Clin. Dementia Rating-Sum of Boxes and Mini Mental State Examn. scores.  The main safety and tolerability findings are amyloid-related imaging abnormalities.  These results justify further development of aducanumab for the treatment of AD.  Should the slowing of clin. decline be confirmed in ongoing phase 3 clin. trials, it would provide compelling support for the amyloid hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojFdrufBYOgbVg90H21EOLACvtfcHk0lg9iHIQXpuBrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCqur%252FJ&md5=62aa713f842093cead6b40cb523417a7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature19323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19323%26sid%3Dliteratum%253Aachs%26aulast%3DSevigny%26aufirst%3DJ.%26aulast%3DChiao%26aufirst%3DP.%26aulast%3DBussiere%26aufirst%3DT.%26aulast%3DWeinreb%26aufirst%3DP.%2BH.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DMaier%26aufirst%3DM.%26aulast%3DDunstan%26aufirst%3DR.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DLing%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Gorman%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DF.%26aulast%3DArastu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DChollate%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DM.%2BS.%26aulast%3DQuintero-Monzon%26aufirst%3DO.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DArnold%26aufirst%3DH.%2BM.%26aulast%3DEngber%26aufirst%3DT.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DFerrero%26aufirst%3DJ.%26aulast%3DHang%26aufirst%3DY.%26aulast%3DMikulskis%26aufirst%3DA.%26aulast%3DGrimm%26aufirst%3DJ.%26aulast%3DHock%26aufirst%3DC.%26aulast%3DNitsch%26aufirst%3DR.%2BM.%26aulast%3DSandrock%26aufirst%3DA.%26atitle%3DThe%2520antibody%2520aducanumab%2520reduces%2520abeta%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2016%26volume%3D537%26spage%3D50%26epage%3D56%26doi%3D10.1038%2Fnature19323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Cheng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K.</span><span> </span><span class="NLM_article-title">Inhibiting toxic aggregation of amyloidogenic proteins: A therapeutic strategy for protein misfolding diseases</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gen. Subj.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1830</span><span class="NLM_x">, </span> <span class="NLM_fpage">4860</span><span class="NLM_x">–</span> <span class="NLM_lpage">4871</span><span class="refDoi"> DOI: 10.1016/j.bbagen.2013.06.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1016%2Fj.bbagen.2013.06.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=23820032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1enu7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1830&publication_year=2013&pages=4860-4871&author=B.+Chengauthor=H.+Gongauthor=H.+Xiaoauthor=R.+B.+Petersenauthor=L.+Zhengauthor=K.+Huang&title=Inhibiting+toxic+aggregation+of+amyloidogenic+proteins%3A+A+therapeutic+strategy+for+protein+misfolding+diseases&doi=10.1016%2Fj.bbagen.2013.06.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting toxic aggregation of amyloidogenic proteins: A therapeutic strategy for protein misfolding diseases</span></div><div class="casAuthors">Cheng, Biao; Gong, Hao; Xiao, Hongwen; Petersen, Robert B.; Zheng, Ling; Huang, Kun</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1830</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4860-4871</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The deposition of self-assembled amyloidogenic proteins is assocd. with multiple diseases, including Alzheimer's disease, Parkinson's disease and type 2 diabetes mellitus.  The toxic misfolding and self-assembling of amyloidogenic proteins are believed to underlie protein misfolding diseases.  Novel drug candidates targeting self-assembled amyloidogenic proteins represent a potential therapeutic approach for protein misfolding diseases.  In this perspective review, the authors provide an overview of the recent progress in identifying inhibitors that block the aggregation of amyloidogenic proteins and the clin. applications thereof.  Compds. such as polyphenols, certain short peptides, and monomer- or oligomer-specific antibodies, can interfere with the self-assembly of amyloidogenic proteins, prevent the formation of oligomers, amyloid fibrils and the consequent cytotoxicity.  Some inhibitors have been tested in clin. trials for treating protein misfolding diseases.  Inhibitors that target the aggregation of amyloidogenic proteins bring new hope to therapy for protein misfolding diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh_uePDq96xLVg90H21EOLACvtfcHk0lg9iHIQXpuBrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1enu7jN&md5=b30394fd1defbbb079dff73eb383915e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2013.06.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2013.06.029%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DB.%26aulast%3DGong%26aufirst%3DH.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DPetersen%26aufirst%3DR.%2BB.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DK.%26atitle%3DInhibiting%2520toxic%2520aggregation%2520of%2520amyloidogenic%2520proteins%253A%2520A%2520therapeutic%2520strategy%2520for%2520protein%2520misfolding%2520diseases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2013%26volume%3D1830%26spage%3D4860%26epage%3D4871%26doi%3D10.1016%2Fj.bbagen.2013.06.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Eisele, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fearns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Encalada, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiseman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. W.</span><span> </span><span class="NLM_article-title">Targeting protein aggregation for the treatment of degenerative diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span><span class="refDoi"> DOI: 10.1038/nrd4593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1038%2Fnrd4593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=26338154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrt7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=759-780&author=Y.+S.+Eiseleauthor=C.+Monteiroauthor=C.+Fearnsauthor=S.+E.+Encaladaauthor=R.+L.+Wisemanauthor=E.+T.+Powersauthor=J.+W.+Kelly&title=Targeting+protein+aggregation+for+the+treatment+of+degenerative+diseases&doi=10.1038%2Fnrd4593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein aggregation for the treatment of degenerative diseases</span></div><div class="casAuthors">Eisele, Yvonne S.; Monteiro, Cecilia; Fearns, Colleen; Encalada, Sandra E.; Wiseman, R. Luke; Powers, Evan T.; Kelly, Jeffery W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">759-780</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The aggregation of specific proteins is hypothesized to underlie several degenerative diseases, which are collectively known as amyloid disorders.  However, the mechanistic connection between the process of protein aggregation and tissue degeneration is not yet fully understood.  Here, we review current and emerging strategies to ameliorate aggregation-assocd. degenerative disorders, with a focus on disease-modifying strategies that prevent the formation of and/or eliminate protein aggregates.  Persuasive pharmacol. and genetic evidence now supports protein aggregation as the cause of postmitotic tissue dysfunction or loss.  However, a more detailed understanding of the factors that trigger and sustain aggregate formation and of the structure-activity relationships underlying proteotoxicity is needed to develop future disease-modifying therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom0hmQxYx0MrVg90H21EOLACvtfcHk0libl0nLut_Ekg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrt7rI&md5=26a6a0e986547aea92da63242fe02292</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd4593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4593%26sid%3Dliteratum%253Aachs%26aulast%3DEisele%26aufirst%3DY.%2BS.%26aulast%3DMonteiro%26aufirst%3DC.%26aulast%3DFearns%26aufirst%3DC.%26aulast%3DEncalada%26aufirst%3DS.%2BE.%26aulast%3DWiseman%26aufirst%3DR.%2BL.%26aulast%3DPowers%26aufirst%3DE.%2BT.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DTargeting%2520protein%2520aggregation%2520for%2520the%2520treatment%2520of%2520degenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D759%26epage%3D780%26doi%3D10.1038%2Fnrd4593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swatton, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spitzfaden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadsworth, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markwell, R. E.</span><span> </span><span class="NLM_article-title">Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span><span class="refDoi"> DOI: 10.1042/bj3400283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1042%2Fbj3400283" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=1999&pages=283-289&issue=1&author=D.+R.+Howlettauthor=A.+E.+Perryauthor=F.+Godfreyauthor=J.+E.+Swattonauthor=K.+H.+Jenningsauthor=C.+Spitzfadenauthor=H.+Wadsworthauthor=S.+J.+Woodauthor=R.+E.+Markwell&title=Inhibition+of+fibril+formation+in+beta-amyloid+peptide+by+a+novel+series+of+benzofurans&doi=10.1042%2Fbj3400283"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1042%2Fbj3400283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3400283%26sid%3Dliteratum%253Aachs%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DPerry%26aufirst%3DA.%2BE.%26aulast%3DGodfrey%26aufirst%3DF.%26aulast%3DSwatton%26aufirst%3DJ.%2BE.%26aulast%3DJennings%26aufirst%3DK.%2BH.%26aulast%3DSpitzfaden%26aufirst%3DC.%26aulast%3DWadsworth%26aufirst%3DH.%26aulast%3DWood%26aufirst%3DS.%2BJ.%26aulast%3DMarkwell%26aufirst%3DR.%2BE.%26atitle%3DInhibition%2520of%2520fibril%2520formation%2520in%2520beta-amyloid%2520peptide%2520by%2520a%2520novel%2520series%2520of%2520benzofurans%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D340%26issue%3D1%26spage%3D283%26epage%3D289%26doi%3D10.1042%2Fbj3400283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haratake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, M.</span><span> </span><span class="NLM_article-title">Novel benzofuran derivatives for pet imaging of beta-amyloid plaques in Alzheimer’s disease brains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2725</span><span class="NLM_x">–</span> <span class="NLM_lpage">2730</span><span class="refDoi"> DOI: 10.1021/jm051176k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051176k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2725-2730&author=M.+Onoauthor=H.+Kawashimaauthor=A.+Nonakaauthor=T.+Kawaiauthor=M.+Haratakeauthor=H.+Moriauthor=M.+P.+Kungauthor=H.+F.+Kungauthor=H.+Sajiauthor=M.+Nakayama&title=Novel+benzofuran+derivatives+for+pet+imaging+of+beta-amyloid+plaques+in+Alzheimer%E2%80%99s+disease+brains&doi=10.1021%2Fjm051176k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm051176k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051176k%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DKawashima%26aufirst%3DH.%26aulast%3DNonaka%26aufirst%3DA.%26aulast%3DKawai%26aufirst%3DT.%26aulast%3DHaratake%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DKung%26aufirst%3DM.%2BP.%26aulast%3DKung%26aufirst%3DH.%2BF.%26aulast%3DSaji%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DM.%26atitle%3DNovel%2520benzofuran%2520derivatives%2520for%2520pet%2520imaging%2520of%2520beta-amyloid%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2725%26epage%3D2730%26doi%3D10.1021%2Fjm051176k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hayne, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly, P. S.</span><span> </span><span class="NLM_article-title">Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">6701</span><span class="NLM_x">–</span> <span class="NLM_lpage">6715</span><span class="refDoi"> DOI: 10.1039/C4CS00026A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1039%2FC4CS00026A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=24671229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mtrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6701-6715&author=D.+J.+Hayneauthor=S.+Limauthor=P.+S.+Donnelly&title=Metal+complexes+designed+to+bind+to+amyloid-%CE%B2+for+the+diagnosis+and+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC4CS00026A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer's disease</span></div><div class="casAuthors">Hayne, David J.; Lim, Sin Chun; Donnelly, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6701-6715</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Alzheimer's disease is the most common form of age-related neurodegenerative dementia.  The disease is characterised by the presence of plaques in the cerebral cortex.  The major constituent of these plaques is aggregated amyloid-β peptide.  This review focuses on the mol. aspects of metal complexes designed to bind to amyloid-β.  The development of radioactive metal-based complexes of copper and technetium designed as diagnostic imaging agents to detect amyloid burden in the brain is discussed.  Sep. sections of the review discuss the use of luminescent metal complexes to act as non-conventional probes of amyloid formation and recent research into the use of metal complexes as inhibitors of amyloid formation and toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQYv3jzy_biLVg90H21EOLACvtfcHk0liyBQmNkqOCpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mtrjN&md5=a8f6f8104ce098d4f9806cfdeab94ff3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1039%2FC4CS00026A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CS00026A%26sid%3Dliteratum%253Aachs%26aulast%3DHayne%26aufirst%3DD.%2BJ.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DDonnelly%26aufirst%3DP.%2BS.%26atitle%3DMetal%2520complexes%2520designed%2520to%2520bind%2520to%2520amyloid-%25CE%25B2%2520for%2520the%2520diagnosis%2520and%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6701%26epage%3D6715%26doi%3D10.1039%2FC4CS00026A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Bajda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzior, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignasik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malawska, B.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands in Alzheimer’s disease treatment</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4949</span><span class="NLM_x">–</span> <span class="NLM_lpage">4975</span><span class="refDoi"> DOI: 10.2174/092986711797535245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.2174%2F092986711797535245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=22050745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4949-4975&author=M.+Bajdaauthor=N.+Guziorauthor=M.+Ignasikauthor=B.+Malawska&title=Multi-target-directed+ligands+in+Alzheimer%E2%80%99s+disease+treatment&doi=10.2174%2F092986711797535245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-directed ligands in Alzheimer's disease treatment</span></div><div class="casAuthors">Bajda, M.; Guzior, N.; Ignasik, M.; Malawska, B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">4949-4975</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Among the various drug discovery methods, a very promising modern approach consists in designing multi-target-directed ligands (MTDLs).  This methodol. has been specifically developed for treatment of disorders with complex pathol. mechanisms.  One such disorder is Alzheimer's disease (AD), currently the most common multifactorial neurodegenerative disease.  AD is related to increased levels of the amyloid β peptide (Aβ) and the hyperphosphorylated tau protein, along with loss of neurons and synapses.  Moreover, there is some evidence pointing to the role of oxidative stress, metal ion deregulation, inflammation and cell cycle regulatory failure in its pathogenesis.  There are many attractive targets for the development of anti-AD drugs, and the multi-factor nature of this disease calls for multi-target-directed compds. which can be beneficial for AD treatment.  This review presents the discovery of dual- and multi-acting anti-AD drug candidates, focusing on the novel design strategy and the compds. it yields - particularly hybrids obtained by linking structurally active moieties interacting with different targets.  The first group of compds. includes cholinesterase inhibitors acting as dual binding site inhibitors and/or inhibitors with addnl. properties.  These compds. are characterized by increased potency against acetylcholinesterase (AChE) and Aβ plaque formation with addnl. properties such as antioxidant activity, neuroprotective, and metal-complexing property, voltage-dependent calcium channel antagonistic activity, inhibitory activity against glutamate-induced excitotoxicity, histamine H3 receptor antagonism, cannabinoid CB1 receptor antagonism and β-secretase (BACE1) inhibition.  A novel class of compds. represents the combination of dual BACE1 inhibitors with metal chelators, and dual modulators of γ-secretase with peroxisome proliferator-activated receptor γ (PPARγ).  We have reviewed the latest reports (2008-2011) presenting new multi-target-directed compds. in Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZHSluHvxy4bVg90H21EOLACvtfcHk0liyBQmNkqOCpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtL3F&md5=c8f35f849c399d43c90570f71ca10e13</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F092986711797535245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797535245%26sid%3Dliteratum%253Aachs%26aulast%3DBajda%26aufirst%3DM.%26aulast%3DGuzior%26aufirst%3DN.%26aulast%3DIgnasik%26aufirst%3DM.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DMulti-target-directed%2520ligands%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4949%26epage%3D4975%26doi%3D10.2174%2F092986711797535245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1002/med.20248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1002%2Fmed.20248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=21793014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Leonauthor=A.+G.+Garciaauthor=J.+Marco-Contelles&title=Recent+advances+in+the+multitarget-directed+ligands+approach+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fmed.20248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Leon, Rafael; Garcia, Antonio G.; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-189</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to nations.  Unless a new medicine capable to delay disease progression is found, the no. of cases will reach 107 million in 2050.  So far, the therapeutic paradigm one-compd.-one-target has failed.  This could be due to the multiple pathogenic mechanisms involved in AD including amyloid β (Aβ) aggregation to form plaques, τ hyperphosphorylation to disrupt microtubule to form neurofibrillary tangles, calcium imbalance, enhanced oxidative stress, impaired mitochondrial function, apoptotic neuronal death, and deterioration of synaptic transmission, particularly at cholinergic neurons.  Approx. 100 compds. are presently been investigated directed to single targets, namely inhibitors of β and γ secretase, vaccines or antibodies that clear Aβ, metal chelators to inhibit Aβ aggregation, blockers of glycogen synthase kinase 3β, enhancers of mitochondrial function, antioxidants, modulators of calcium-permeable channels such as voltage-dependent calcium channels, N-methyl-D-aspartate receptors for glutamate, or enhancers of cholinergic neurotransmission such as inhibitors of acetylcholinesterase or butyrylcholinesterase.  In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compd. targeting two or more of the pathogenic mechanisms leading to neuronal death.  This review summarizes the current therapeutic strategies based on the paradigm one-compd.-various targets to treat AD.  A treatment that delays disease onset and/or progression by 5 years could halve the no. of people requiring institutionalization and/or dying from AD.  © 2011 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YQ_Czzj5brVg90H21EOLACvtfcHk0lgNWLQzWkGBIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL&md5=b08806a8a4ca71c35a3594338c881e74</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fmed.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20248%26sid%3Dliteratum%253Aachs%26aulast%3DLeon%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520multitarget-directed%2520ligands%2520approach%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189%26doi%3D10.1002%2Fmed.20248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Dias, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viegas, C.,  Jr.</span><span> </span><span class="NLM_article-title">Multi-target directed drugs: A modern approach for design of new drugs for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.2174/1570159X1203140511153200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.2174%2F1570159X1203140511153200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=24851088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A280%3ADC%252BC2cjltFSqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=239-255&author=K.+S.+Diasauthor=C.+Viegas&title=Multi-target+directed+drugs%3A+A+modern+approach+for+design+of+new+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1570159X1203140511153200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer's Disease</span></div><div class="casAuthors">Dias Kris Simone Tranches; Viegas Claudio Jr</div><div class="citationInfo"><span class="NLM_cas:title">Current neuropharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-55</span>
        ISSN:<span class="NLM_cas:issn">1570-159X</span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a complex neurodegenerative disorder with a multi-faceted pathogenesis.  So far, the therapeutic paradigm "one-compound-one-target" has failed and despite enormous efforts to elucidate the pathophysiology of AD, the disease is still incurable.  The multiple factors involved in AD include amyloid aggregation to form insoluble neurotoxic plaques of Aβ, hyperphosphorylation of tau protein, oxidative stress, calcium imbalance, mitochondrial dysfunction and deterioration of synaptic transmission.  These factors together, accentuate changes in the CNS homeostasis, starting a complex process of interconnected physiological damage, leading to cognitive and memory impairment and neuronal death.  A recent approach for the rational design of new drug candidates, also called multitarget-directed ligand (MTDL) approach, has gained increasing attention by many research groups, which have developed a variety of hybrid compounds acting simultaneously on diverse biological targets.  This review aims to show some recent advances and examples of the exploitation of MTDL approach in the rational design of novel drug candidate prototypes for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYe5S6uW60kOR_TJajKxJDfW6udTcc2eYuLtTE12OLdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjltFSqtg%253D%253D&md5=799f606126ae0ca12411a25515de14e2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F1570159X1203140511153200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X1203140511153200%26sid%3Dliteratum%253Aachs%26aulast%3DDias%26aufirst%3DK.%2BS.%26aulast%3DViegas%26aufirst%3DC.%26atitle%3DMulti-target%2520directed%2520drugs%253A%2520A%2520modern%2520approach%2520for%2520design%2520of%2520new%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2014%26volume%3D12%26spage%3D239%26epage%3D255%26doi%3D10.2174%2F1570159X1203140511153200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Multi-target directed donepezil-like ligands for Alzheimer’s disease</span> <span class="citation_source-journal">Front. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="refDoi"> DOI: 10.3389/fnins.2016.00205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.3389%2Ffnins.2016.00205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=27252617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FmtV2hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=205&author=M.+Unzetaauthor=G.+Estebanauthor=I.+Boleaauthor=W.+A.+Fogelauthor=R.+R.+Ramsayauthor=M.+B.+Youdimauthor=K.+F.+Tiptonauthor=J.+Marco-Contelles&title=Multi-target+directed+donepezil-like+ligands+for+Alzheimer%E2%80%99s+disease&doi=10.3389%2Ffnins.2016.00205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease</span></div><div class="casAuthors">Unzeta Mercedes; Bolea Irene; Esteban Gerard; Tipton Keith F; Fogel Wieslawa A; Ramsay Rona R; Youdim Moussa B H; Marco-Contelles Jose</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">205</span>
        ISSN:<span class="NLM_cas:issn">1662-4548</span>.
    </div><div class="casAbstract">HIGHLIGHTS ASS234 is a MTDL compound containing a moiety from Donepezil and the propargyl group from the PF 9601N, a potent and selective MAO B inhibitor.  This compound is the most advanced anti-Alzheimer agent for preclinical studies identified in our laboratory.Derived from ASS234 both multipotent donepezil-indolyl (MTDL-1) and donepezil-pyridyl hybrids (MTDL-2) were designed and evaluated as inhibitors of AChE/BuChE and both MAO isoforms.  MTDL-2 showed more high affinity toward the four enzymes than MTDL-1.MTDL-3 and MTDL-4, were designed containing the N-benzylpiperidinium moiety from Donepezil, a metal- chelating 8-hydroxyquinoline group and linked to a N-propargyl core and they were pharmacologically evaluated.The presence of the cyano group in MTDL-3, enhanced binding to AChE, BuChE and MAO A.  It showed antioxidant behavior and it was able to strongly complex Cu(II), Zn(II) and Fe(III).MTDL-4 showed higher affinity toward AChE, BuChE.MTDL-3 exhibited good brain penetration capacity (ADMET) and less toxicity than Donepezil.  Memory deficits in scopolamine-lesioned animals were restored by MTDL-3.MTDL-3 particularly emerged as a ligand showing remarkable potential benefits for its use in AD therapy.  Alzheimer's disease (AD), the most common form of adult onset dementia, is an age-related neurodegenerative disorder characterized by progressive memory loss, decline in language skills, and other cognitive impairments.  Although its etiology is not completely known, several factors including deficits of acetylcholine, β-amyloid deposits, τ-protein phosphorylation, oxidative stress, and neuroinflammation are considered to play significant roles in the pathophysiology of this disease.  For a long time, AD patients have been treated with acetylcholinesterase inhibitors such as donepezil (Aricept®) but with limited therapeutic success.  This might be due to the complex multifactorial nature of AD, a fact that has prompted the design of new Multi-Target-Directed Ligands (MTDL) based on the "one molecule, multiple targets" paradigm.  Thus, in this context, different series of novel multifunctional molecules with antioxidant, anti-amyloid, anti-inflammatory, and metal-chelating properties able to interact with multiple enzymes of therapeutic interest in AD pathology including acetylcholinesterase, butyrylcholinesterase, and monoamine oxidases A and B have been designed and assessed biologically.  This review describes the multiple targets, the design rationale and an in-house MTDL library, bearing the N-benzylpiperidine motif present in donepezil, linked to different heterocyclic ring systems (indole, pyridine, or 8-hydroxyquinoline) with special emphasis on compound ASS234, an N-propargylindole derivative.  The description of the in vitro biological properties of the compounds and discussion of the corresponding structure-activity-relationships allows us to highlight new issues for the identification of more efficient MTDL for use in AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAKdUtVDXRPgpJitSxOdIlfW6udTcc2eYuLtTE12OLdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FmtV2hsw%253D%253D&md5=0904cb1e4e1c700e575e192e9d3bebb3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3389%2Ffnins.2016.00205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnins.2016.00205%26sid%3Dliteratum%253Aachs%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DEsteban%26aufirst%3DG.%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DFogel%26aufirst%3DW.%2BA.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DMulti-target%2520directed%2520donepezil-like%2520ligands%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Neurosci.%26date%3D2016%26volume%3D10%26spage%3D205%26doi%3D10.3389%2Ffnins.2016.00205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Navigating the chemical space of multitarget-directed ligands: From hybrids to fragments in Alzheimer’s disease</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="refDoi"> DOI: 10.3390/molecules21040466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.3390%2Fmolecules21040466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=27070562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWktLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=466&author=F.+Pratiauthor=A.+Cavalliauthor=M.+L.+Bolognesi&title=Navigating+the+chemical+space+of+multitarget-directed+ligands%3A+From+hybrids+to+fragments+in+Alzheimer%E2%80%99s+disease&doi=10.3390%2Fmolecules21040466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Navigating the chemical space of multitarget-directed ligands: from hybrids to fragments in Alzheimer's disease</span></div><div class="casAuthors">Prati, Federica; Cavalli, Andrea; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">466/1-466/12</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Multitarget drug discovery is one of the hottest topics and most active fields in the search for new mols. against Alzheimer's disease (AD).  Over the last 20 years, many promising multitarget-directed ligands (MTDLs) have been identified and developed at a pre-clin. level.  However, how to design them in a rational way remains the most fundamental challenge of medicinal chemists.  This is related to the foundational question of achieving an optimized activity towards multiple targets of interest, while preserving drug-like properties.  In this respect, large hybrid mols. and small fragments are poles apart.  In this review article, our aim is to appraise what we have accomplished in the development of both hybrid- and fragment-like mols. directed to diverse AD targets (i.e., acetylcholinesterase, NMDA receptors, metal chelation, BACE-1 and GSK-3β).  In addn., we attempt to highlight what are the persistent needs that deserve to be improved and cared for, with the ultimate goal of moving an MTDL to AD clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAXsoof4raqbVg90H21EOLACvtfcHk0lhC7O9QPt8eZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWktLjI&md5=3653a0ef6b41711663e8d2f2d4ae74f6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21040466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21040466%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DNavigating%2520the%2520chemical%2520space%2520of%2520multitarget-directed%2520ligands%253A%2520From%2520hybrids%2520to%2520fragments%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D466%26doi%3D10.3390%2Fmolecules21040466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Rizzo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riviere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morroni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, beta amyloid aggregation, and abeta neurotoxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2883</span><span class="NLM_x">–</span> <span class="NLM_lpage">2886</span><span class="refDoi"> DOI: 10.1021/jm8002747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8002747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2883-2886&author=S.+Rizzoauthor=C.+Riviereauthor=L.+Piazziauthor=A.+Bisiauthor=S.+Gobbiauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=F.+Morroniauthor=A.+Tarozziauthor=J.+P.+Montiauthor=A.+Rampa&title=Benzofuran-based+hybrid+compounds+for+the+inhibition+of+cholinesterase+activity%2C+beta+amyloid+aggregation%2C+and+abeta+neurotoxicity&doi=10.1021%2Fjm8002747"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm8002747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8002747%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DS.%26aulast%3DRiviere%26aufirst%3DC.%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DMorroni%26aufirst%3DF.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DJ.%2BP.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DBenzofuran-based%2520hybrid%2520compounds%2520for%2520the%2520inhibition%2520of%2520cholinesterase%2520activity%252C%2520beta%2520amyloid%2520aggregation%252C%2520and%2520abeta%2520neurotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2883%26epage%3D2886%26doi%3D10.1021%2Fjm8002747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Rizzo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Costa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligresti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrelia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">2-arylbenzofuran-based molecules as multipotent Alzheimer’s disease modifying agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.10.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1016%2Fj.ejmech.2012.10.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2012&pages=519-532&author=S.+Rizzoauthor=A.+Tarozziauthor=M.+Bartoliniauthor=G.+Da+Costaauthor=A.+Bisiauthor=S.+Gobbiauthor=F.+Bellutiauthor=A.+Ligrestiauthor=M.+Allaraauthor=J.+P.+Montiauthor=V.+Andrisanoauthor=V.+Di+Marzoauthor=P.+Hreliaauthor=A.+Rampa&title=2-arylbenzofuran-based+molecules+as+multipotent+Alzheimer%E2%80%99s+disease+modifying+agents&doi=10.1016%2Fj.ejmech.2012.10.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.10.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.10.045%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DS.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDa%2BCosta%26aufirst%3DG.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DAllara%26aufirst%3DM.%26aulast%3DMonti%26aufirst%3DJ.%2BP.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DHrelia%26aufirst%3DP.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3D2-arylbenzofuran-based%2520molecules%2520as%2520multipotent%2520Alzheimer%25E2%2580%2599s%2520disease%2520modifying%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D58%26spage%3D519%26epage%3D532%26doi%3D10.1016%2Fj.ejmech.2012.10.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Pan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.-M.</span><span> </span><span class="NLM_article-title">An efficient method to synthesize benzofurans and naphthofurans</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1657</span><span class="NLM_x">–</span> <span class="NLM_lpage">1662</span><span class="refDoi"> DOI: 10.1055/s-2006-944204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1055%2Fs-2006-944204" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=1657-1662&issue=11&author=C.+Panauthor=J.+Yuauthor=Y.+Zhouauthor=Z.+Wangauthor=M.-M.+Zhou&title=An+efficient+method+to+synthesize+benzofurans+and+naphthofurans&doi=10.1055%2Fs-2006-944204"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-944204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-944204%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DM.-M.%26atitle%3DAn%2520efficient%2520method%2520to%2520synthesize%2520benzofurans%2520and%2520naphthofurans%26jtitle%3DSynlett%26date%3D2006%26volume%3D2006%26issue%3D11%26spage%3D1657%26epage%3D1662%26doi%3D10.1055%2Fs-2006-944204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lorenzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yankner, B. A.</span><span> </span><span class="NLM_article-title">Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">12243</span><span class="NLM_x">–</span> <span class="NLM_lpage">12247</span><span class="refDoi"> DOI: 10.1073/pnas.91.25.12243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1073%2Fpnas.91.25.12243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=7991613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADyaK2MXisF2jsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=12243-12247&author=A.+Lorenzoauthor=B.+A.+Yankner&title=Beta-amyloid+neurotoxicity+requires+fibril+formation+and+is+inhibited+by+congo+red&doi=10.1073%2Fpnas.91.25.12243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red</span></div><div class="casAuthors">Lorenzo, Alfredo; Yankner, Bruce A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">12243-7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">β-Amyloid (βA) is normally produced as a nontoxic sol. peptide.  In Alzheimer disease, βA aggregates and accumulates in the brain as inert diffuse plaques or compact plaques assocd. with neurodegenerative changes.  To det. the relation of neurotoxicity to the phys. state of βA, the authors created (i) nonamyloidogenic amorphous aggregates of βA [amorphous βA (Am-βA)] analogous to diffuse plaques and (ii) amyloidogenic fibrils of βA [fibrillar βA (Fib-βA)] analogous to compact plaques.  In primary rat hippocampal culture, Fib-βA was neurotoxic, whereas Am-βA was not toxic.  Fib-βA caused significant loss of synapses in viable neurons, while Am-βA had no effect on synapse no.  The amyloid fibril-binding dye Congo red inhibited Fib-βA neurotoxicity by inhibiting fibril formation or by binding to preformed fibrils.  Congo red also inhibited the pancreatic islet cell toxicity of diabetes-assocd. amylin, another type of amyloid fibril.  These results indicate that βA neurotoxicity requires fibril formation.  These findings and the authors previous demonstration that amylin fibrils are toxic suggest that a common cytopathic effect of amyloid fibrils may contribute to the pathogenesis of Alzheimer disease and other amyloidoses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1ScYUorh19rVg90H21EOLACvtfcHk0lhNRPGWvdDs3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXisF2jsL4%253D&md5=b38ab117cc8a54b20c315a02ca92ea1f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.25.12243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.25.12243%26sid%3Dliteratum%253Aachs%26aulast%3DLorenzo%26aufirst%3DA.%26aulast%3DYankner%26aufirst%3DB.%2BA.%26atitle%3DBeta-amyloid%2520neurotoxicity%2520requires%2520fibril%2520formation%2520and%2520is%2520inhibited%2520by%2520congo%2520red%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D12243%26epage%3D12247%26doi%3D10.1073%2Fpnas.91.25.12243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Song, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, T.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, H.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huh, S.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paek, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, Y.-H.</span><span> </span><span class="NLM_article-title">Behavioral and neuropathologic changes induced by central injection of carboxyl-terminal fragment of β-amyloid precursor protein in mice</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">878</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.1998.71020875.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1046%2Fj.1471-4159.1998.71020875.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=9681480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADyaK1cXkslKksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1998&pages=875-878&author=D.-K.+Songauthor=M.-H.+Wonauthor=J.-S.+Jungauthor=J.-C.+Leeauthor=T.-C.+Kangauthor=H.-W.+Suhauthor=S.-O.+Huhauthor=S.-H.+Paekauthor=Y.-H.+Kimauthor=S.-H.+Kimauthor=Y.-H.+Suh&title=Behavioral+and+neuropathologic+changes+induced+by+central+injection+of+carboxyl-terminal+fragment+of+%CE%B2-amyloid+precursor+protein+in+mice&doi=10.1046%2Fj.1471-4159.1998.71020875.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral and neuropathologic changes induced by central injection of carboxyl-terminal fragment of β-amyloid precursor protein in mice</span></div><div class="casAuthors">Song, D. K.; Won, M. H.; Jung, J. S.; Lee, J. C.; Kang, T. C.; Suh, H. W.; Huh, S. O.; Paek, S. H.; Kim, Y. H.; Kim, S. H.; Suh, Y. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">875-878</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">Expression of the carboxyl-terminal fragment (CT) of the β-amyloid precursor protein (APP) in transgenic animals has been linked with neurotoxicity.  However, it remains to be clarified whether the neurotoxicity is caused by β-amyloid proteins (Aβs) derived from CT or by CT itself.  To study the in vivo neurotoxicity of CT, mice were given a single intracerebroventricular injection of a recombinant 105-amino acid CT (CT105; 68.5-685 pmol, intracerebroventricularly), and changes in behavior and in brain histol. were examd.  Animals given CT105 (410 or 685 pmol, intracerebroventricularly) showed a dose-dependent impairment in the passive avoidance performance, whereas boiled CT105 had no effect.  CT105 (685 pmol, intracerebroventricularly) induced reactive gliosis in neocortex and hippocampus and neurodegeneration in neocortex.  These results indicate that centrally administered CT105 induces behavioral impairment and neuropathol. changes, suggesting a direct toxic effect of CT105 per se.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp372URWd1pybVg90H21EOLACvtfcHk0lhNRPGWvdDs3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkslKksbs%253D&md5=5598c8ae756d5e77fb7493f9e8ccaebf</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1998.71020875.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1998.71020875.x%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DD.-K.%26aulast%3DWon%26aufirst%3DM.-H.%26aulast%3DJung%26aufirst%3DJ.-S.%26aulast%3DLee%26aufirst%3DJ.-C.%26aulast%3DKang%26aufirst%3DT.-C.%26aulast%3DSuh%26aufirst%3DH.-W.%26aulast%3DHuh%26aufirst%3DS.-O.%26aulast%3DPaek%26aufirst%3DS.-H.%26aulast%3DKim%26aufirst%3DY.-H.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DSuh%26aufirst%3DY.-H.%26atitle%3DBehavioral%2520and%2520neuropathologic%2520changes%2520induced%2520by%2520central%2520injection%2520of%2520carboxyl-terminal%2520fragment%2520of%2520%25CE%25B2-amyloid%2520precursor%2520protein%2520in%2520mice%26jtitle%3DJ.%2520Neurochem.%26date%3D1998%26volume%3D71%26spage%3D875%26epage%3D878%26doi%3D10.1046%2Fj.1471-4159.1998.71020875.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Cheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBlanc, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span> </span><span class="NLM_article-title">Triptolide preserves cognitive function and reduces neuropathology in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e108845</span><span class="refDoi"> DOI: 10.1371/journal.pone.0108845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1371%2Fjournal.pone.0108845" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e108845&author=S.+Chengauthor=K.+J.+LeBlancauthor=L.+Li&title=Triptolide+preserves+cognitive+function+and+reduces+neuropathology+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0108845"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0108845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0108845%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DS.%26aulast%3DLeBlanc%26aufirst%3DK.%2BJ.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DTriptolide%2520preserves%2520cognitive%2520function%2520and%2520reduces%2520neuropathology%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De108845%26doi%3D10.1371%2Fjournal.pone.0108845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Diana Lamaa, Camille Hauguel, Hsin-Ping Lin, Estelle Messe, Vincent Gandon, Mouad Alami, <span class="NLM_string-name hlFld-ContribAuthor">Abdallah Hamze</span>. </span><span class="cited-content_cbyCitation_article-title">Sequential One-Pot Synthesis of 3-Arylbenzofurans from N-Tosylhydrazones and Bromophenol Derivatives. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (21)
                                     , 13664-13673. <a href="https://doi.org/10.1021/acs.joc.0c01835" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01835%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSequential%252BOne-Pot%252BSynthesis%252Bof%252B3-Arylbenzofurans%252Bfrom%252BN-Tosylhydrazones%252Band%252BBromophenol%252BDerivatives%26aulast%3DLamaa%26aufirst%3DDiana%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30072020%26date%3D22102020%26volume%3D85%26issue%3D21%26spage%3D13664%26epage%3D13673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Geng</span>, <span class="hlFld-ContribAuthor ">Yu‐chen  Pan</span>, <span class="hlFld-ContribAuthor ">Ran  Zhang</span>, <span class="hlFld-ContribAuthor ">Dong  Gao</span>, <span class="hlFld-ContribAuthor ">Zijuan  Wang</span>, <span class="hlFld-ContribAuthor ">Boying  Li</span>, <span class="hlFld-ContribAuthor ">Ning  Li</span>, <span class="hlFld-ContribAuthor ">Dong‐sheng  Guo</span>, <span class="hlFld-ContribAuthor ">Chengfen  Xing</span>. </span><span class="cited-content_cbyCitation_article-title">Binding to Amyloid‐β Protein by Photothermal Blood‐Brain Barrier‐Penetrating Nanoparticles for Inhibition and Disaggregation of Fibrillation. </span><span class="cited-content_cbyCitation_journal-name">Advanced Functional Materials</span><span> <strong>2021,</strong> <em> </em>, 2102953. <a href="https://doi.org/10.1002/adfm.202102953" title="DOI URL">https://doi.org/10.1002/adfm.202102953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adfm.202102953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadfm.202102953%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Functional%2520Materials%26atitle%3DBinding%252Bto%252BAmyloid%2525E2%252580%252590%2525CE%2525B2%252BProtein%252Bby%252BPhotothermal%252BBlood%2525E2%252580%252590Brain%252BBarrier%2525E2%252580%252590Penetrating%252BNanoparticles%252Bfor%252BInhibition%252Band%252BDisaggregation%252Bof%252BFibrillation%26aulast%3DGeng%26aufirst%3DHao%26date%3D2021%26date%3D2021%26spage%3D2102953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiacheng  Zhou</span>, <span class="hlFld-ContribAuthor ">Tianci  Li</span>, <span class="hlFld-ContribAuthor ">Meichao  Li</span>, <span class="hlFld-ContribAuthor ">Chunmei  Li</span>, <span class="hlFld-ContribAuthor ">Xinquan  Hu</span>, <span class="hlFld-ContribAuthor ">Liqun  Jin</span>, <span class="hlFld-ContribAuthor ">Nan  Sun</span>, <span class="hlFld-ContribAuthor ">Baoxiang  Hu</span>, <span class="hlFld-ContribAuthor ">Zhenlu  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">FeCl
              2
              ‐Catalyzed Direct C
              2
              ‐Benzylation of Benzofurans with Diarylmethanes via Cross Dehydrogenative Coupling. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>10 </em>
                                    (3)
                                     , 549-553. <a href="https://doi.org/10.1002/ajoc.202100006" title="DOI URL">https://doi.org/10.1002/ajoc.202100006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202100006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202100006%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFeCl%252B2%252B%2525E2%252580%252590Catalyzed%252BDirect%252BC%252B2%252B%2525E2%252580%252590Benzylation%252Bof%252BBenzofurans%252Bwith%252BDiarylmethanes%252Bvia%252BCross%252BDehydrogenative%252BCoupling%26aulast%3DZhou%26aufirst%3DJiacheng%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D3%26spage%3D549%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio  Arcadi</span>, <span class="hlFld-ContribAuthor ">Giancarlo  Fabrizi</span>, <span class="hlFld-ContribAuthor ">Andrea  Fochetti</span>, <span class="hlFld-ContribAuthor ">Francesca  Ghirga</span>, <span class="hlFld-ContribAuthor ">Antonella  Goggiamani</span>, <span class="hlFld-ContribAuthor ">Antonia  Iazzetti</span>, <span class="hlFld-ContribAuthor ">Federico  Marrone</span>, <span class="hlFld-ContribAuthor ">Giulia  Mazzoccanti</span>, <span class="hlFld-ContribAuthor ">Andrea  Serraiocco</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-catalyzed Tsuji–Trost-type reaction of benzofuran-2-ylmethyl acetates with nucleophiles. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (2)
                                     , 909-917. <a href="https://doi.org/10.1039/D0RA09601F" title="DOI URL">https://doi.org/10.1039/D0RA09601F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA09601F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA09601F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DPalladium-catalyzed%252BTsuji%2525E2%252580%252593Trost-type%252Breaction%252Bof%252Bbenzofuran-2-ylmethyl%252Bacetates%252Bwith%252Bnucleophiles%26aulast%3DArcadi%26aufirst%3DAntonio%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D2%26spage%3D909%26epage%3D917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Geng</span>, <span class="hlFld-ContribAuthor ">Hongbo  Yuan</span>, <span class="hlFld-ContribAuthor ">Liang  Qiu</span>, <span class="hlFld-ContribAuthor ">Dong  Gao</span>, <span class="hlFld-ContribAuthor ">Yongqiang  Cheng</span>, <span class="hlFld-ContribAuthor ">Chengfen  Xing</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition and disaggregation of amyloid β protein fibrils through conjugated polymer–core thermoresponsive micelles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Materials Chemistry B</span><span> <strong>2020,</strong> <em>8 </em>
                                    (44)
                                     , 10126-10135. <a href="https://doi.org/10.1039/D0TB01863E" title="DOI URL">https://doi.org/10.1039/D0TB01863E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0TB01863E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0TB01863E%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Materials%2520Chemistry%2520B%26atitle%3DInhibition%252Band%252Bdisaggregation%252Bof%252Bamyloid%252B%2525CE%2525B2%252Bprotein%252Bfibrils%252Bthrough%252Bconjugated%252Bpolymer%2525E2%252580%252593core%252Bthermoresponsive%252Bmicelles%26aulast%3DGeng%26aufirst%3DHao%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D44%26spage%3D10126%26epage%3D10135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samra  Khan</span>, <span class="hlFld-ContribAuthor ">Muhammad  Tariq</span>, <span class="hlFld-ContribAuthor ">Muhammad  Ashraf</span>, <span class="hlFld-ContribAuthor ">Shawana  Abdullah</span>, <span class="hlFld-ContribAuthor ">Mariya  al-Rashida</span>, <span class="hlFld-ContribAuthor ">Muhammad  Khalid</span>, <span class="hlFld-ContribAuthor ">Parham  Taslimi</span>, <span class="hlFld-ContribAuthor ">Mehwish  Fatima</span>, <span class="hlFld-ContribAuthor ">Rafia  Zafar</span>, <span class="hlFld-ContribAuthor ">Zahid  Shafiq</span>. </span><span class="cited-content_cbyCitation_article-title">Probing 2-acetylbenzofuran hydrazones and their metal complexes as α-glucosidase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>102 </em>, 104082. <a href="https://doi.org/10.1016/j.bioorg.2020.104082" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104082%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DProbing%252B2-acetylbenzofuran%252Bhydrazones%252Band%252Btheir%252Bmetal%252Bcomplexes%252Bas%252B%2525CE%2525B1-glucosidase%252Binhibitors%26aulast%3DKhan%26aufirst%3DSamra%26date%3D2020%26volume%3D102%26spage%3D104082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Khalid</span>, <span class="hlFld-ContribAuthor ">Muhammad Nadeem  Arshad</span>, <span class="hlFld-ContribAuthor ">Muhammad Nawaz  Tahir</span>, <span class="hlFld-ContribAuthor ">Abdullah M.  Asiri</span>, <span class="hlFld-ContribAuthor ">Muhammad Moazzam  Naseer</span>, <span class="hlFld-ContribAuthor ">Muhammad  Ishaq</span>, <span class="hlFld-ContribAuthor ">Muhammad Usman  Khan</span>, <span class="hlFld-ContribAuthor ">Zahid  Shafiq</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis, structural (SC-XRD) and spectroscopic (FTIR, 1HNMR, MS spectroscopic) characterization of novel benzofuran-based hydrazones: An experimental and theoretical studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1216 </em>, 128318. <a href="https://doi.org/10.1016/j.molstruc.2020.128318" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.128318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.128318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.128318%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DAn%252Befficient%252Bsynthesis%25252C%252Bstructural%252B%252528SC-XRD%252529%252Band%252Bspectroscopic%252B%252528FTIR%25252C%252B1HNMR%25252C%252BMS%252Bspectroscopic%252529%252Bcharacterization%252Bof%252Bnovel%252Bbenzofuran-based%252Bhydrazones%25253A%252BAn%252Bexperimental%252Band%252Btheoretical%252Bstudies%26aulast%3DKhalid%26aufirst%3DMuhammad%26date%3D2020%26volume%3D1216%26spage%3D128318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinghong  Liao</span>, <span class="hlFld-ContribAuthor ">Qi  Li</span>, <span class="hlFld-ContribAuthor ">Yifan  Zhao</span>, <span class="hlFld-ContribAuthor ">Pan  Jiang</span>, <span class="hlFld-ContribAuthor ">Yuhui  Yan</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wei  Qu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103844. <a href="https://doi.org/10.1016/j.bioorg.2020.103844" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103844</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103844%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bcarboline-cinnamic%252Bacid%252Bhybrids%252Bas%252Bmultifunctional%252Bagents%252Bfor%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DLiao%26aufirst%3DQinghong%26date%3D2020%26volume%3D99%26spage%3D103844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangpu  Liu</span>, <span class="hlFld-ContribAuthor ">Yang  Jiao</span>, <span class="hlFld-ContribAuthor ">Yongqiang  Lin</span>, <span class="hlFld-ContribAuthor ">Haifang  Hao</span>, <span class="hlFld-ContribAuthor ">Yanli  Dou</span>, <span class="hlFld-ContribAuthor ">Juan  Yang</span>, <span class="hlFld-ContribAuthor ">Cheng-Shi  Jiang</span>, <span class="hlFld-ContribAuthor ">Ping  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Biological Evaluation of New Selective Acetylcholinesterase Inhibitors with Anti-Aβ Aggregation Activity through Molecular Docking-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2020,</strong> <em>68 </em>
                                    (2)
                                     , 161-166. <a href="https://doi.org/10.1248/cpb.c19-00927" title="DOI URL">https://doi.org/10.1248/cpb.c19-00927</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c19-00927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c19-00927%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DDiscovery%252Band%252BBiological%252BEvaluation%252Bof%252BNew%252BSelective%252BAcetylcholinesterase%252BInhibitors%252Bwith%252BAnti-A%2525CE%2525B2%252BAggregation%252BActivity%252Bthrough%252BMolecular%252BDocking-Based%252BVirtual%252BScreening%26aulast%3DLiu%26aufirst%3DGuangpu%26date%3D2020%26volume%3D68%26issue%3D2%26spage%3D161%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaime R.  Cabrera-Pardo</span>, <span class="hlFld-ContribAuthor ">Jorge  Fuentealba</span>, <span class="hlFld-ContribAuthor ">Javiera  Gavilán</span>, <span class="hlFld-ContribAuthor ">Daniel  Cajas</span>, <span class="hlFld-ContribAuthor ">José  Becerra</span>, <span class="hlFld-ContribAuthor ">Mariola  Napiórkowska</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the Multi–Target Neuroprotective Chemical Space of Benzofuran Scaffolds: A New Strategy in Drug Development for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fphar.2019.01679" title="DOI URL">https://doi.org/10.3389/fphar.2019.01679</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2019.01679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2019.01679%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DExploring%252Bthe%252BMulti%2525E2%252580%252593Target%252BNeuroprotective%252BChemical%252BSpace%252Bof%252BBenzofuran%252BScaffolds%25253A%252BA%252BNew%252BStrategy%252Bin%252BDrug%252BDevelopment%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DCabrera-Pardo%26aufirst%3DJaime%2BR.%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julin  Gong</span>, <span class="hlFld-ContribAuthor ">Kun  Hu</span>, <span class="hlFld-ContribAuthor ">Yinlin  Shao</span>, <span class="hlFld-ContribAuthor ">Renhao  Li</span>, <span class="hlFld-ContribAuthor ">Yetong  Zhang</span>, <span class="hlFld-ContribAuthor ">Maolin  Hu</span>, <span class="hlFld-ContribAuthor ">Jiuxi  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Tandem addition/cyclization for synthesis of 2-aroyl benzofurans and 2-aroyl indoles by carbopalladation of nitriles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (3)
                                     , 488-494. <a href="https://doi.org/10.1039/C9OB02408E" title="DOI URL">https://doi.org/10.1039/C9OB02408E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB02408E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB02408E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DTandem%252Baddition%25252Fcyclization%252Bfor%252Bsynthesis%252Bof%252B2-aroyl%252Bbenzofurans%252Band%252B2-aroyl%252Bindoles%252Bby%252Bcarbopalladation%252Bof%252Bnitriles%26aulast%3DGong%26aufirst%3DJulin%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D3%26spage%3D488%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kamal M  Dawood</span>. </span><span class="cited-content_cbyCitation_article-title">An update on benzofuran inhibitors: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2019,</strong> <em>29 </em>
                                    (11)
                                     , 841-870. <a href="https://doi.org/10.1080/13543776.2019.1673727" title="DOI URL">https://doi.org/10.1080/13543776.2019.1673727</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2019.1673727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2019.1673727%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DAn%252Bupdate%252Bon%252Bbenzofuran%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%26aulast%3DDawood%26aufirst%3DKamal%2BM%26date%3D2019%26date%3D2019%26volume%3D29%26issue%3D11%26spage%3D841%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-hang  Miao</span>, <span class="hlFld-ContribAuthor ">Yu-heng  Hu</span>, <span class="hlFld-ContribAuthor ">Jie  Yang</span>, <span class="hlFld-ContribAuthor ">Teng  Liu</span>, <span class="hlFld-ContribAuthor ">Jie  Sun</span>, <span class="hlFld-ContribAuthor ">Xiao-jing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Natural source, bioactivity and synthesis of benzofuran derivatives. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (47)
                                     , 27510-27540. <a href="https://doi.org/10.1039/C9RA04917G" title="DOI URL">https://doi.org/10.1039/C9RA04917G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA04917G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA04917G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DNatural%252Bsource%25252C%252Bbioactivity%252Band%252Bsynthesis%252Bof%252Bbenzofuran%252Bderivatives%26aulast%3DMiao%26aufirst%3DYu-hang%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D47%26spage%3D27510%26epage%3D27540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neng  Jiang</span>, <span class="hlFld-ContribAuthor ">Jiaoli  Ding</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaona  Sun</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Mo</span>, <span class="hlFld-ContribAuthor ">Xiao  Li</span>, <span class="hlFld-ContribAuthor ">Hong  Yin</span>, <span class="hlFld-ContribAuthor ">Weizhong  Tang</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Novel chromanone-dithiocarbamate hybrids as multifunctional AChE inhibitors with β-amyloid anti-aggregation properties for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>89 </em>, 103027. <a href="https://doi.org/10.1016/j.bioorg.2019.103027" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252Bchromanone-dithiocarbamate%252Bhybrids%252Bas%252Bmultifunctional%252BAChE%252Binhibitors%252Bwith%252B%2525CE%2525B2-amyloid%252Banti-aggregation%252Bproperties%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DJiang%26aufirst%3DNeng%26date%3D2019%26volume%3D89%26spage%3D103027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinzhuan  Wang</span>, <span class="hlFld-ContribAuthor ">Kun  Wang</span>, <span class="hlFld-ContribAuthor ">Zhenzhu  Zhu</span>, <span class="hlFld-ContribAuthor ">Yafeng  He</span>, <span class="hlFld-ContribAuthor ">Changli  Zhang</span>, <span class="hlFld-ContribAuthor ">Zijian  Guo</span>, <span class="hlFld-ContribAuthor ">Xiaoyong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of metal-induced amyloid β-peptide aggregation by a blood–brain barrier permeable silica–cyclen nanochelator. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (25)
                                     , 14126-14131. <a href="https://doi.org/10.1039/C9RA02358E" title="DOI URL">https://doi.org/10.1039/C9RA02358E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA02358E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA02358E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DInhibition%252Bof%252Bmetal-induced%252Bamyloid%252B%2525CE%2525B2-peptide%252Baggregation%252Bby%252Ba%252Bblood%2525E2%252580%252593brain%252Bbarrier%252Bpermeable%252Bsilica%2525E2%252580%252593cyclen%252Bnanochelator%26aulast%3DWang%26aufirst%3DJinzhuan%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D25%26spage%3D14126%26epage%3D14131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaqiong  Dong</span>, <span class="hlFld-ContribAuthor ">Tessandra  Stewart</span>, <span class="hlFld-ContribAuthor ">Yue  Zhang</span>, <span class="hlFld-ContribAuthor ">Min  Shi</span>, <span class="hlFld-ContribAuthor ">Chang  Tan</span>, <span class="hlFld-ContribAuthor ">Xue  Li</span>, <span class="hlFld-ContribAuthor ">Lan  Yuan</span>, <span class="hlFld-ContribAuthor ">Aanchal  Mehrotra</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoda  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-diabetic vanadyl complexes reduced Alzheimer’s disease pathology independent of amyloid plaque deposition. </span><span class="cited-content_cbyCitation_journal-name">Science China Life Sciences</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 126-139. <a href="https://doi.org/10.1007/s11427-018-9350-1" title="DOI URL">https://doi.org/10.1007/s11427-018-9350-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11427-018-9350-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11427-018-9350-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520China%2520Life%2520Sciences%26atitle%3DAnti-diabetic%252Bvanadyl%252Bcomplexes%252Breduced%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bpathology%252Bindependent%252Bof%252Bamyloid%252Bplaque%252Bdeposition%26aulast%3DDong%26aufirst%3DYaqiong%26date%3D2019%26date%3D2018%26volume%3D62%26issue%3D1%26spage%3D126%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pragati  Kushwaha</span>, <span class="hlFld-ContribAuthor ">Soobiya  Fatima</span>, <span class="hlFld-ContribAuthor ">Akanksha  Upadhyay</span>, <span class="hlFld-ContribAuthor ">Sampa  Gupta</span>, <span class="hlFld-ContribAuthor ">Sudha  Bhagwati</span>, <span class="hlFld-ContribAuthor ">Tanvi  Baghel</span>, <span class="hlFld-ContribAuthor ">M.I.  Siddiqi</span>, <span class="hlFld-ContribAuthor ">Aamir  Nazir</span>, <span class="hlFld-ContribAuthor ">Koneni V.  Sashidhara</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and molecular dynamic simulations of novel Benzofuran-tetrazole derivatives as potential agents against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (1)
                                     , 66-72. <a href="https://doi.org/10.1016/j.bmcl.2018.11.005" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bdynamic%252Bsimulations%252Bof%252Bnovel%252BBenzofuran-tetrazole%252Bderivatives%252Bas%252Bpotential%252Bagents%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DKushwaha%26aufirst%3DPragati%26date%3D2019%26volume%3D29%26issue%3D1%26spage%3D66%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Baldisserotto</span>, <span class="hlFld-ContribAuthor ">Monica  Demurtas</span>, <span class="hlFld-ContribAuthor ">Ilaria  Lampronti</span>, <span class="hlFld-ContribAuthor ">Davide  Moi</span>, <span class="hlFld-ContribAuthor ">Gianfranco  Balboni</span>, <span class="hlFld-ContribAuthor ">Silvia  Vertuani</span>, <span class="hlFld-ContribAuthor ">Stefano  Manfredini</span>, <span class="hlFld-ContribAuthor ">Valentina  Onnis</span>. </span><span class="cited-content_cbyCitation_article-title">Benzofuran hydrazones as potential scaffold in the development of multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>156 </em>, 118-125. <a href="https://doi.org/10.1016/j.ejmech.2018.07.001" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.07.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.07.001%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzofuran%252Bhydrazones%252Bas%252Bpotential%252Bscaffold%252Bin%252Bthe%252Bdevelopment%252Bof%252Bmultifunctional%252Bdrugs%25253A%252BSynthesis%252Band%252Bevaluation%252Bof%252Bantioxidant%25252C%252Bphotoprotective%252Band%252Bantiproliferative%252Bactivity%26aulast%3DBaldisserotto%26aufirst%3DAnna%26date%3D2018%26volume%3D156%26spage%3D118%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. β-Amyloid aggregation inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Scale-Up Synthesis of <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DBU, CH<sub>3</sub>CN, rt, 3 h; (b) I<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, THF, reflux, 4 h; (c) LiOH, MeOH–H<sub>2</sub>O, 50 °C, 3 h; (d) (i) NaBH<sub>4</sub>, THF, reflux, 1 h, (ii) I<sub>2</sub>, THF, reflux, 4 h; (e) MeI, <i>t</i>-BuOK, THF, rt, 2 h.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of <b>8</b> on (a) the aggregation of monomeric Aβ<sub>1–42</sub> and (b) the disaggregation of Aβ fibrils in vitro. ThT assays were performed by incubating 25 μM monomeric Aβ<sub>1–42</sub> solutions (a) or preformed Aβ aggregates (b) with <b>8</b> at the indicated concentrations. The data are presented as the mean ± SD from three independent experiments: one-way ANOVA, Dunnett test, (∗) <i>p</i> < 0.001 vs control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Effect of <b>8</b> on the cell viability of the HT22 cells exposed to Aβ aggregates. (b) Effect of <b>8</b> on cell viability without the treatment of Aβ aggregates. HT22 cells were treated with preformed Aβ aggregates that were prepared by using 25 μM monomeric Aβ solutions. The data are presented as the mean ± SD from three independent experiments: one-way ANOVA, Dunnett test, (∗) <i>p</i> < 0.001 vs control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of <b>8</b> on preformed Aβ aggregates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Behavioral effects of <b>8</b> in an acute AD model mice: (a) passive avoidance tests to assess learning and memory impairments; (b) Y maze tests to assess spatial memory function ((##) <i>P</i> < 0.01 vs control, (∗) <i>P</i> < 0.05, (∗∗) <i>P</i> < 0.01 vs vehicle).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Y-maze tests following <b>8</b> treatment in APP/PS1 mice: (∗) <i>P</i> < 0.05, (∗∗) <i>P</i> < 0.01 vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) Aβ<sub>1–40</sub> and (b) Aβ<sub>1–42</sub> levels in the brains of APP/PS1 transgenic mice treated with <b>8</b>: (∗∗) <i>P</i> < 0.01 vs vehicle. The brain Aβ levels were quantified by using the antibodies specific to monomeric Aβ, after brain tissues were homogenized and amyloid fibrils were solubilized to monomers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/medium/jm-2017-00844u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Blood–brain barrier permeability of <b>8</b>. ICR mice (<i>n</i> = 3) were orally administered 10 mg/kg of <b>8</b>. <i>K</i><sub>p</sub> indicates AUC<sub>brain</sub>/AUC<sub>plasma</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b00844/20180110/images/large/jm-2017-00844u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00844&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38533" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38533" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 27 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Knowles, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendruscolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, C. M.</span><span> </span><span class="NLM_article-title">The amyloid state and its association with protein misfolding diseases</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span><span class="refDoi"> DOI: 10.1038/nrm3810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1038%2Fnrm3810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=24854788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosV2lurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=384-396&author=T.+P.+Knowlesauthor=M.+Vendruscoloauthor=C.+M.+Dobson&title=The+amyloid+state+and+its+association+with+protein+misfolding+diseases&doi=10.1038%2Fnrm3810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid state and its association with protein misfolding diseases</span></div><div class="casAuthors">Knowles, Tuomas P. J.; Vendruscolo, Michele; Dobson, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">384-396</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phenomenon of protein aggregation and amyloid formation has become the subject of rapidly increasing research activities across a wide range of scientific disciplines.  Such activities have been stimulated by the assocn. of amyloid deposition with a range of debilitating medical disorders, from Alzheimer's disease to type II diabetes, many of which are major threats to human health and welfare in the modern world.  It has become clear, however, that the ability to form the amyloid state is more general than previously imagined, and that its study can provide unique insights into the nature of the functional forms of peptides and proteins, as well as understanding the means by which protein homeostasis can be maintained and protein metastasis avoided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryuIN_Qt8Fa7Vg90H21EOLACvtfcHk0lj_HoAoH3zStA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosV2lurk%253D&md5=68e2e4d963646f1daca50ab3288f5a37</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm3810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3810%26sid%3Dliteratum%253Aachs%26aulast%3DKnowles%26aufirst%3DT.%2BP.%26aulast%3DVendruscolo%26aufirst%3DM.%26aulast%3DDobson%26aufirst%3DC.%2BM.%26atitle%3DThe%2520amyloid%2520state%2520and%2520its%2520association%2520with%2520protein%2520misfolding%2520diseases%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D384%26epage%3D396%26doi%3D10.1038%2Fnrm3810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+Progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lj556F9O6xNwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Berk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, M. N.</span><span> </span><span class="NLM_article-title">Successes and failures for drugs in late-stage development for Alzheimer’s disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">792</span><span class="refDoi"> DOI: 10.1007/s40266-013-0108-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1007%2Fs40266-013-0108-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=23943247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=783-792&author=C.+Berkauthor=M.+N.+Sabbagh&title=Successes+and+failures+for+drugs+in+late-stage+development+for+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs40266-013-0108-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Successes and Failures for Drugs in Late-Stage Development for Alzheimer's Disease</span></div><div class="casAuthors">Berk, Camryn; Sabbagh, Marwan N.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">783-792</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  To date, symptomatic medications prevail as the mainstay of treatment options for Alzheimer's disease (AD).  There have been tremendous investments made to increase the nos. of drugs approved and the targets engaged, in an effort to alter the disease course or pathophysiol. of AD.  Unfortunately, almost all studies have not met expectations and no new drug (beyond medical foods) has been approved for the treatment of AD in the last decade.  This review is a comparison of novel AD therapies in the late phases of clin. testing, including recent high-profile clin. failures, and agents in development with relatively unexplored mechanisms of action, with a focus on their potential as therapeutic agents and their proposed advantages over the treatments currently in use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru8C4Zf__NMrVg90H21EOLACvtfcHk0lj556F9O6xNwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bM&md5=92a0562710d6e1e36ce087d1457a936c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs40266-013-0108-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-013-0108-6%26sid%3Dliteratum%253Aachs%26aulast%3DBerk%26aufirst%3DC.%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26atitle%3DSuccesses%2520and%2520failures%2520for%2520drugs%2520in%2520late-stage%2520development%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDrugs%2520Aging%26date%3D2013%26volume%3D30%26spage%3D783%26epage%3D792%26doi%3D10.1007%2Fs40266-013-0108-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Lessons from a failed gamma-secretase alzheimer trial</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1016/j.cell.2014.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1016%2Fj.cell.2014.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=25417150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2msrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2014&pages=721-726&author=B.+De+Strooper&title=Lessons+from+a+failed+gamma-secretase+alzheimer+trial&doi=10.1016%2Fj.cell.2014.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from a Failed γ-Secretase Alzheimer Trial</span></div><div class="casAuthors">De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">721-726</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  γ-Secretase proteases have been assocd. with pathol. in Alzheimer disease (AD), but we are just beginning to understand their basic mechanisms and physiol. roles.  A neg. drug trial with a broad spectrum γ-secretase inhibitor in AD patients has severely dampened enthusiasm for the potential of pursuing γ-secretase research therapeutically.  This pessimism is unwarranted: anal. of available information presented here demonstrates significant confounds for interpreting the outcome of the trial and argues that the major lessons pertain to broad knowledge gaps that are imperative to fill.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoltWoN44tWybVg90H21EOLACvtfcHk0lj556F9O6xNwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2msrnI&md5=9d19644a7135552c6c4ef2b812b4b665</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DLessons%2520from%2520a%2520failed%2520gamma-secretase%2520alzheimer%2520trial%26jtitle%3DCell%26date%3D2014%26volume%3D159%26spage%3D721%26epage%3D726%26doi%3D10.1016%2Fj.cell.2014.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Yu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span> </span><span class="NLM_article-title">Developing therapeutic antibodies for neurodegenerative disease</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span><span class="refDoi"> DOI: 10.1007/s13311-013-0187-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1007%2Fs13311-013-0187-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=459-472&author=Y.+J.+Yuauthor=R.+J.+Watts&title=Developing+therapeutic+antibodies+for+neurodegenerative+disease&doi=10.1007%2Fs13311-013-0187-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs13311-013-0187-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-013-0187-4%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%2BJ.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26atitle%3DDeveloping%2520therapeutic%2520antibodies%2520for%2520neurodegenerative%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2013%26volume%3D10%26spage%3D459%26epage%3D472%26doi%3D10.1007%2Fs13311-013-0187-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Mullard, A.</span><span> </span><span class="NLM_article-title">Alzheimer amyloid hypothesis lives on</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span><span class="refDoi"> DOI: 10.1038/nrd.2016.281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1038%2Fnrd.2016.281" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=3-5&author=A.+Mullard&title=Alzheimer+amyloid+hypothesis+lives+on&doi=10.1038%2Fnrd.2016.281"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.281%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DAlzheimer%2520amyloid%2520hypothesis%2520lives%2520on%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D16%26spage%3D3%26epage%3D5%26doi%3D10.1038%2Fnrd.2016.281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Saraiva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Praca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardino, L.</span><span> </span><span class="NLM_article-title">Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">235</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><span class="refDoi"> DOI: 10.1016/j.jconrel.2016.05.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1016%2Fj.jconrel.2016.05.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=27208862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC28XovV2hsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=2016&pages=34-47&author=C.+Saraivaauthor=C.+Pracaauthor=R.+Ferreiraauthor=T.+Santosauthor=L.+Ferreiraauthor=L.+Bernardino&title=Nanoparticle-mediated+brain+drug+delivery%3A+Overcoming+blood-brain+barrier+to+treat+neurodegenerative+diseases&doi=10.1016%2Fj.jconrel.2016.05.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases</span></div><div class="casAuthors">Saraiva, Claudia; Praca, Catarina; Ferreira, Raquel; Santos, Tiago; Ferreira, Lino; Bernardino, Liliana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-47</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) is a vital boundary between neural tissue and circulating blood.  The BBB's unique and protective features control brain homeostasis as well as ion and mol. movement.  Failure in maintaining any of these components results in the breakdown of this specialized multicellular structure and consequently promotes neuro inflammation and neurodegeneration.  In several high incidence pathologies such as stroke, Alzheimer's (AD) and Parkinson's disease (PD) the BBB is impaired.  However, even a damaged and more permeable BBB can pose serious challenges to drug delivery into the brain.  The use of nanoparticle (NP) formulations able to encapsulate mols. with therapeutic value, while targeting specific transport processes in the brain vasculature, may enhance drug transport through the BBB in neurodegenerative/ischemic disorders and target relevant regions in the brain for regenerative processes.  In this review, we will discuss BBB compn. and characteristics and how these features are altered in pathol., namely in stroke, AD and PD.  Addnl., factors influencing an efficient i.v. delivery of polymeric and inorg. NPs into the brain as well as NP-related delivery systems with the most promising functional outcomes will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaTfl3mFXDRLVg90H21EOLACvtfcHk0ljKfUuglK8m3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XovV2hsbY%253D&md5=9a656f4dfad25bb41b0d8e4996822031</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2016.05.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2016.05.044%26sid%3Dliteratum%253Aachs%26aulast%3DSaraiva%26aufirst%3DC.%26aulast%3DPraca%26aufirst%3DC.%26aulast%3DFerreira%26aufirst%3DR.%26aulast%3DSantos%26aufirst%3DT.%26aulast%3DFerreira%26aufirst%3DL.%26aulast%3DBernardino%26aufirst%3DL.%26atitle%3DNanoparticle-mediated%2520brain%2520drug%2520delivery%253A%2520Overcoming%2520blood-brain%2520barrier%2520to%2520treat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2016%26volume%3D235%26spage%3D34%26epage%3D47%26doi%3D10.1016%2Fj.jconrel.2016.05.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Neves, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aires-da-Silva, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corte-Real, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanho, M. A.</span><span> </span><span class="NLM_article-title">Antibody approaches to treat brain diseases</span> <span class="citation_source-journal">Trends Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span><span class="refDoi"> DOI: 10.1016/j.tibtech.2015.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1016%2Fj.tibtech.2015.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslyrt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=36-48&author=V.+Nevesauthor=F.+Aires-da-Silvaauthor=S.+Corte-Realauthor=M.+A.+Castanho&title=Antibody+approaches+to+treat+brain+diseases&doi=10.1016%2Fj.tibtech.2015.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody Approaches To Treat Brain Diseases</span></div><div class="casAuthors">Neves, Vera; Aires-da-Silva, Frederico; Corte-Real, Sofia; Castanho, Miguel A. R. B.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biotechnology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-48</span>CODEN:
                <span class="NLM_cas:coden">TRBIDM</span>;
        ISSN:<span class="NLM_cas:issn">0167-7799</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Recombinant antibodies are an emerging class of therapeutics with substantial promise to treat central nervous system (CNS) diseases such as Alzheimer's, Parkinson's, stroke, and brain cancers.  However, poor blood-brain barrier (BBB) permeability hinders the progress of antibody therapies for conditions in which the target is located in the brain.  Nonetheless, antibodies can nowadays be engineered to enhance their therapeutic applications and translocation of the BBB using the natural portals of the brain.  This paper reviews advances in the development and engineering of therapeutic BBB-crossing antibodies and their high potential for treatment of CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLNJVWm-r4LVg90H21EOLACvtfcHk0ljKfUuglK8m3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslyrt7vJ&md5=7d61a17720858884f59dd180ba6d9f54</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.tibtech.2015.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibtech.2015.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DNeves%26aufirst%3DV.%26aulast%3DAires-da-Silva%26aufirst%3DF.%26aulast%3DCorte-Real%26aufirst%3DS.%26aulast%3DCastanho%26aufirst%3DM.%2BA.%26atitle%3DAntibody%2520approaches%2520to%2520treat%2520brain%2520diseases%26jtitle%3DTrends%2520Biotechnol.%26date%3D2016%26volume%3D34%26spage%3D36%26epage%3D48%26doi%3D10.1016%2Fj.tibtech.2015.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Mullard, A.</span><span> </span><span class="NLM_article-title">Sting of Alzheimer’s failures offset by upcoming prevention trials</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span><span class="refDoi"> DOI: 10.1038/nrd3842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1038%2Fnrd3842" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=657-660&author=A.+Mullard&title=Sting+of+Alzheimer%E2%80%99s+failures+offset+by+upcoming+prevention+trials&doi=10.1038%2Fnrd3842"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd3842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3842%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DSting%2520of%2520Alzheimer%25E2%2580%2599s%2520failures%2520offset%2520by%2520upcoming%2520prevention%2520trials%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D657%26epage%3D660%26doi%3D10.1038%2Fnrd3842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Reardon, S.</span><span> </span><span class="NLM_article-title">Antibody drugs for Alzheimer’s show glimmers of promise</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">523</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">510</span><span class="refDoi"> DOI: 10.1038/nature.2015.18031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1038%2Fnature.2015.18031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=523&publication_year=2015&pages=509-510&author=S.+Reardon&title=Antibody+drugs+for+Alzheimer%E2%80%99s+show+glimmers+of+promise&doi=10.1038%2Fnature.2015.18031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature.2015.18031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature.2015.18031%26sid%3Dliteratum%253Aachs%26aulast%3DReardon%26aufirst%3DS.%26atitle%3DAntibody%2520drugs%2520for%2520Alzheimer%25E2%2580%2599s%2520show%2520glimmers%2520of%2520promise%26jtitle%3DNature%26date%3D2015%26volume%3D523%26spage%3D509%26epage%3D510%26doi%3D10.1038%2Fnature.2015.18031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sevigny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunstan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Gorman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arastu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollate, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintero-Monzon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikulskis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitsch, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandrock, A.</span><span> </span><span class="NLM_article-title">The antibody aducanumab reduces abeta plaques in Alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">537</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1038/nature19323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1038%2Fnature19323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=27582220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCqur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=537&publication_year=2016&pages=50-56&author=J.+Sevignyauthor=P.+Chiaoauthor=T.+Bussiereauthor=P.+H.+Weinrebauthor=L.+Williamsauthor=M.+Maierauthor=R.+Dunstanauthor=S.+Sallowayauthor=T.+Chenauthor=Y.+Lingauthor=J.+O%E2%80%99Gormanauthor=F.+Qianauthor=M.+Arastuauthor=M.+Liauthor=S.+Chollateauthor=M.+S.+Brennanauthor=O.+Quintero-Monzonauthor=R.+H.+Scannevinauthor=H.+M.+Arnoldauthor=T.+Engberauthor=K.+Rhodesauthor=J.+Ferreroauthor=Y.+Hangauthor=A.+Mikulskisauthor=J.+Grimmauthor=C.+Hockauthor=R.+M.+Nitschauthor=A.+Sandrock&title=The+antibody+aducanumab+reduces+abeta+plaques+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnature19323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The antibody aducanumab reduces Aβ plaques in Alzheimer's disease</span></div><div class="casAuthors">Sevigny, Jeff; Chiao, Ping; Bussiere, Thierry; Weinreb, Paul H.; Williams, Leslie; Maier, Marcel; Dunstan, Robert; Salloway, Stephen; Chen, Tianle; Ling, Yan; O'Gorman, John; Qian, Fang; Arastu, Mahin; Li, Mingwei; Chollate, Sowmya; Brennan, Melanie S.; Quintero-Monzon, Omar; Scannevin, Robert H.; Arnold, H. Moore; Engber, Thomas; Rhodes, Kenneth; Ferrero, James; Hang, Yaming; Mikulskis, Alvydas; Grimm, Jan; Hock, Christoph; Nitsch, Roger M.; Sandrock, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">537</span>
        (<span class="NLM_cas:issue">7618</span>),
    <span class="NLM_cas:pages">50-56</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles in the brain, accompanied by synaptic dysfunction and neurodegeneration.  Antibody-based immunotherapy against Aβ to trigger its clearance or mitigate its neurotoxicity has so far been unsuccessful.  Here we report the generation of aducanumab, a human monoclonal antibody that selectively targets aggregated Aβ.  In a transgenic mouse model of AD, aducanumab is shown to enter the brain, bind parenchymal Aβ, and reduce sol. and insol. Aβ in a dose-dependent manner.  In patients with prodromal or mild AD, one year of monthly i.v. infusions of aducanumab reduces brain Aβ in a dose- and time-dependent manner.  This is accompanied by a slowing of clin. decline measured by Clin. Dementia Rating-Sum of Boxes and Mini Mental State Examn. scores.  The main safety and tolerability findings are amyloid-related imaging abnormalities.  These results justify further development of aducanumab for the treatment of AD.  Should the slowing of clin. decline be confirmed in ongoing phase 3 clin. trials, it would provide compelling support for the amyloid hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojFdrufBYOgbVg90H21EOLACvtfcHk0lhj0KNjsxnx9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCqur%252FJ&md5=62aa713f842093cead6b40cb523417a7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature19323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19323%26sid%3Dliteratum%253Aachs%26aulast%3DSevigny%26aufirst%3DJ.%26aulast%3DChiao%26aufirst%3DP.%26aulast%3DBussiere%26aufirst%3DT.%26aulast%3DWeinreb%26aufirst%3DP.%2BH.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DMaier%26aufirst%3DM.%26aulast%3DDunstan%26aufirst%3DR.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DLing%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Gorman%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DF.%26aulast%3DArastu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DChollate%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DM.%2BS.%26aulast%3DQuintero-Monzon%26aufirst%3DO.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DArnold%26aufirst%3DH.%2BM.%26aulast%3DEngber%26aufirst%3DT.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DFerrero%26aufirst%3DJ.%26aulast%3DHang%26aufirst%3DY.%26aulast%3DMikulskis%26aufirst%3DA.%26aulast%3DGrimm%26aufirst%3DJ.%26aulast%3DHock%26aufirst%3DC.%26aulast%3DNitsch%26aufirst%3DR.%2BM.%26aulast%3DSandrock%26aufirst%3DA.%26atitle%3DThe%2520antibody%2520aducanumab%2520reduces%2520abeta%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2016%26volume%3D537%26spage%3D50%26epage%3D56%26doi%3D10.1038%2Fnature19323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Cheng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K.</span><span> </span><span class="NLM_article-title">Inhibiting toxic aggregation of amyloidogenic proteins: A therapeutic strategy for protein misfolding diseases</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gen. Subj.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1830</span><span class="NLM_x">, </span> <span class="NLM_fpage">4860</span><span class="NLM_x">–</span> <span class="NLM_lpage">4871</span><span class="refDoi"> DOI: 10.1016/j.bbagen.2013.06.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1016%2Fj.bbagen.2013.06.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=23820032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1enu7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1830&publication_year=2013&pages=4860-4871&author=B.+Chengauthor=H.+Gongauthor=H.+Xiaoauthor=R.+B.+Petersenauthor=L.+Zhengauthor=K.+Huang&title=Inhibiting+toxic+aggregation+of+amyloidogenic+proteins%3A+A+therapeutic+strategy+for+protein+misfolding+diseases&doi=10.1016%2Fj.bbagen.2013.06.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting toxic aggregation of amyloidogenic proteins: A therapeutic strategy for protein misfolding diseases</span></div><div class="casAuthors">Cheng, Biao; Gong, Hao; Xiao, Hongwen; Petersen, Robert B.; Zheng, Ling; Huang, Kun</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1830</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4860-4871</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The deposition of self-assembled amyloidogenic proteins is assocd. with multiple diseases, including Alzheimer's disease, Parkinson's disease and type 2 diabetes mellitus.  The toxic misfolding and self-assembling of amyloidogenic proteins are believed to underlie protein misfolding diseases.  Novel drug candidates targeting self-assembled amyloidogenic proteins represent a potential therapeutic approach for protein misfolding diseases.  In this perspective review, the authors provide an overview of the recent progress in identifying inhibitors that block the aggregation of amyloidogenic proteins and the clin. applications thereof.  Compds. such as polyphenols, certain short peptides, and monomer- or oligomer-specific antibodies, can interfere with the self-assembly of amyloidogenic proteins, prevent the formation of oligomers, amyloid fibrils and the consequent cytotoxicity.  Some inhibitors have been tested in clin. trials for treating protein misfolding diseases.  Inhibitors that target the aggregation of amyloidogenic proteins bring new hope to therapy for protein misfolding diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh_uePDq96xLVg90H21EOLACvtfcHk0lhj0KNjsxnx9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1enu7jN&md5=b30394fd1defbbb079dff73eb383915e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2013.06.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2013.06.029%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DB.%26aulast%3DGong%26aufirst%3DH.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DPetersen%26aufirst%3DR.%2BB.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DK.%26atitle%3DInhibiting%2520toxic%2520aggregation%2520of%2520amyloidogenic%2520proteins%253A%2520A%2520therapeutic%2520strategy%2520for%2520protein%2520misfolding%2520diseases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2013%26volume%3D1830%26spage%3D4860%26epage%3D4871%26doi%3D10.1016%2Fj.bbagen.2013.06.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Eisele, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fearns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Encalada, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiseman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. W.</span><span> </span><span class="NLM_article-title">Targeting protein aggregation for the treatment of degenerative diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span><span class="refDoi"> DOI: 10.1038/nrd4593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1038%2Fnrd4593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=26338154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrt7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=759-780&author=Y.+S.+Eiseleauthor=C.+Monteiroauthor=C.+Fearnsauthor=S.+E.+Encaladaauthor=R.+L.+Wisemanauthor=E.+T.+Powersauthor=J.+W.+Kelly&title=Targeting+protein+aggregation+for+the+treatment+of+degenerative+diseases&doi=10.1038%2Fnrd4593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein aggregation for the treatment of degenerative diseases</span></div><div class="casAuthors">Eisele, Yvonne S.; Monteiro, Cecilia; Fearns, Colleen; Encalada, Sandra E.; Wiseman, R. Luke; Powers, Evan T.; Kelly, Jeffery W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">759-780</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The aggregation of specific proteins is hypothesized to underlie several degenerative diseases, which are collectively known as amyloid disorders.  However, the mechanistic connection between the process of protein aggregation and tissue degeneration is not yet fully understood.  Here, we review current and emerging strategies to ameliorate aggregation-assocd. degenerative disorders, with a focus on disease-modifying strategies that prevent the formation of and/or eliminate protein aggregates.  Persuasive pharmacol. and genetic evidence now supports protein aggregation as the cause of postmitotic tissue dysfunction or loss.  However, a more detailed understanding of the factors that trigger and sustain aggregate formation and of the structure-activity relationships underlying proteotoxicity is needed to develop future disease-modifying therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom0hmQxYx0MrVg90H21EOLACvtfcHk0liF_humUg6DOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrt7rI&md5=26a6a0e986547aea92da63242fe02292</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd4593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4593%26sid%3Dliteratum%253Aachs%26aulast%3DEisele%26aufirst%3DY.%2BS.%26aulast%3DMonteiro%26aufirst%3DC.%26aulast%3DFearns%26aufirst%3DC.%26aulast%3DEncalada%26aufirst%3DS.%2BE.%26aulast%3DWiseman%26aufirst%3DR.%2BL.%26aulast%3DPowers%26aufirst%3DE.%2BT.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DTargeting%2520protein%2520aggregation%2520for%2520the%2520treatment%2520of%2520degenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D759%26epage%3D780%26doi%3D10.1038%2Fnrd4593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swatton, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spitzfaden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadsworth, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markwell, R. E.</span><span> </span><span class="NLM_article-title">Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span><span class="refDoi"> DOI: 10.1042/bj3400283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1042%2Fbj3400283" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=1999&pages=283-289&issue=1&author=D.+R.+Howlettauthor=A.+E.+Perryauthor=F.+Godfreyauthor=J.+E.+Swattonauthor=K.+H.+Jenningsauthor=C.+Spitzfadenauthor=H.+Wadsworthauthor=S.+J.+Woodauthor=R.+E.+Markwell&title=Inhibition+of+fibril+formation+in+beta-amyloid+peptide+by+a+novel+series+of+benzofurans&doi=10.1042%2Fbj3400283"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1042%2Fbj3400283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3400283%26sid%3Dliteratum%253Aachs%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DPerry%26aufirst%3DA.%2BE.%26aulast%3DGodfrey%26aufirst%3DF.%26aulast%3DSwatton%26aufirst%3DJ.%2BE.%26aulast%3DJennings%26aufirst%3DK.%2BH.%26aulast%3DSpitzfaden%26aufirst%3DC.%26aulast%3DWadsworth%26aufirst%3DH.%26aulast%3DWood%26aufirst%3DS.%2BJ.%26aulast%3DMarkwell%26aufirst%3DR.%2BE.%26atitle%3DInhibition%2520of%2520fibril%2520formation%2520in%2520beta-amyloid%2520peptide%2520by%2520a%2520novel%2520series%2520of%2520benzofurans%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D340%26issue%3D1%26spage%3D283%26epage%3D289%26doi%3D10.1042%2Fbj3400283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haratake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, M.</span><span> </span><span class="NLM_article-title">Novel benzofuran derivatives for pet imaging of beta-amyloid plaques in Alzheimer’s disease brains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2725</span><span class="NLM_x">–</span> <span class="NLM_lpage">2730</span><span class="refDoi"> DOI: 10.1021/jm051176k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051176k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2725-2730&author=M.+Onoauthor=H.+Kawashimaauthor=A.+Nonakaauthor=T.+Kawaiauthor=M.+Haratakeauthor=H.+Moriauthor=M.+P.+Kungauthor=H.+F.+Kungauthor=H.+Sajiauthor=M.+Nakayama&title=Novel+benzofuran+derivatives+for+pet+imaging+of+beta-amyloid+plaques+in+Alzheimer%E2%80%99s+disease+brains&doi=10.1021%2Fjm051176k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm051176k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051176k%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DKawashima%26aufirst%3DH.%26aulast%3DNonaka%26aufirst%3DA.%26aulast%3DKawai%26aufirst%3DT.%26aulast%3DHaratake%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DKung%26aufirst%3DM.%2BP.%26aulast%3DKung%26aufirst%3DH.%2BF.%26aulast%3DSaji%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DM.%26atitle%3DNovel%2520benzofuran%2520derivatives%2520for%2520pet%2520imaging%2520of%2520beta-amyloid%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2725%26epage%3D2730%26doi%3D10.1021%2Fjm051176k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hayne, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly, P. S.</span><span> </span><span class="NLM_article-title">Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">6701</span><span class="NLM_x">–</span> <span class="NLM_lpage">6715</span><span class="refDoi"> DOI: 10.1039/C4CS00026A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1039%2FC4CS00026A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=24671229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mtrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6701-6715&author=D.+J.+Hayneauthor=S.+Limauthor=P.+S.+Donnelly&title=Metal+complexes+designed+to+bind+to+amyloid-%CE%B2+for+the+diagnosis+and+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC4CS00026A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer's disease</span></div><div class="casAuthors">Hayne, David J.; Lim, Sin Chun; Donnelly, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6701-6715</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Alzheimer's disease is the most common form of age-related neurodegenerative dementia.  The disease is characterised by the presence of plaques in the cerebral cortex.  The major constituent of these plaques is aggregated amyloid-β peptide.  This review focuses on the mol. aspects of metal complexes designed to bind to amyloid-β.  The development of radioactive metal-based complexes of copper and technetium designed as diagnostic imaging agents to detect amyloid burden in the brain is discussed.  Sep. sections of the review discuss the use of luminescent metal complexes to act as non-conventional probes of amyloid formation and recent research into the use of metal complexes as inhibitors of amyloid formation and toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQYv3jzy_biLVg90H21EOLACvtfcHk0lj662daqtGGFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mtrjN&md5=a8f6f8104ce098d4f9806cfdeab94ff3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1039%2FC4CS00026A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CS00026A%26sid%3Dliteratum%253Aachs%26aulast%3DHayne%26aufirst%3DD.%2BJ.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DDonnelly%26aufirst%3DP.%2BS.%26atitle%3DMetal%2520complexes%2520designed%2520to%2520bind%2520to%2520amyloid-%25CE%25B2%2520for%2520the%2520diagnosis%2520and%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6701%26epage%3D6715%26doi%3D10.1039%2FC4CS00026A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Bajda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzior, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignasik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malawska, B.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands in Alzheimer’s disease treatment</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4949</span><span class="NLM_x">–</span> <span class="NLM_lpage">4975</span><span class="refDoi"> DOI: 10.2174/092986711797535245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.2174%2F092986711797535245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=22050745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4949-4975&author=M.+Bajdaauthor=N.+Guziorauthor=M.+Ignasikauthor=B.+Malawska&title=Multi-target-directed+ligands+in+Alzheimer%E2%80%99s+disease+treatment&doi=10.2174%2F092986711797535245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-directed ligands in Alzheimer's disease treatment</span></div><div class="casAuthors">Bajda, M.; Guzior, N.; Ignasik, M.; Malawska, B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">4949-4975</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Among the various drug discovery methods, a very promising modern approach consists in designing multi-target-directed ligands (MTDLs).  This methodol. has been specifically developed for treatment of disorders with complex pathol. mechanisms.  One such disorder is Alzheimer's disease (AD), currently the most common multifactorial neurodegenerative disease.  AD is related to increased levels of the amyloid β peptide (Aβ) and the hyperphosphorylated tau protein, along with loss of neurons and synapses.  Moreover, there is some evidence pointing to the role of oxidative stress, metal ion deregulation, inflammation and cell cycle regulatory failure in its pathogenesis.  There are many attractive targets for the development of anti-AD drugs, and the multi-factor nature of this disease calls for multi-target-directed compds. which can be beneficial for AD treatment.  This review presents the discovery of dual- and multi-acting anti-AD drug candidates, focusing on the novel design strategy and the compds. it yields - particularly hybrids obtained by linking structurally active moieties interacting with different targets.  The first group of compds. includes cholinesterase inhibitors acting as dual binding site inhibitors and/or inhibitors with addnl. properties.  These compds. are characterized by increased potency against acetylcholinesterase (AChE) and Aβ plaque formation with addnl. properties such as antioxidant activity, neuroprotective, and metal-complexing property, voltage-dependent calcium channel antagonistic activity, inhibitory activity against glutamate-induced excitotoxicity, histamine H3 receptor antagonism, cannabinoid CB1 receptor antagonism and β-secretase (BACE1) inhibition.  A novel class of compds. represents the combination of dual BACE1 inhibitors with metal chelators, and dual modulators of γ-secretase with peroxisome proliferator-activated receptor γ (PPARγ).  We have reviewed the latest reports (2008-2011) presenting new multi-target-directed compds. in Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZHSluHvxy4bVg90H21EOLACvtfcHk0lj662daqtGGFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtL3F&md5=c8f35f849c399d43c90570f71ca10e13</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F092986711797535245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797535245%26sid%3Dliteratum%253Aachs%26aulast%3DBajda%26aufirst%3DM.%26aulast%3DGuzior%26aufirst%3DN.%26aulast%3DIgnasik%26aufirst%3DM.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DMulti-target-directed%2520ligands%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4949%26epage%3D4975%26doi%3D10.2174%2F092986711797535245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1002/med.20248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1002%2Fmed.20248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=21793014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Leonauthor=A.+G.+Garciaauthor=J.+Marco-Contelles&title=Recent+advances+in+the+multitarget-directed+ligands+approach+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fmed.20248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Leon, Rafael; Garcia, Antonio G.; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-189</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to nations.  Unless a new medicine capable to delay disease progression is found, the no. of cases will reach 107 million in 2050.  So far, the therapeutic paradigm one-compd.-one-target has failed.  This could be due to the multiple pathogenic mechanisms involved in AD including amyloid β (Aβ) aggregation to form plaques, τ hyperphosphorylation to disrupt microtubule to form neurofibrillary tangles, calcium imbalance, enhanced oxidative stress, impaired mitochondrial function, apoptotic neuronal death, and deterioration of synaptic transmission, particularly at cholinergic neurons.  Approx. 100 compds. are presently been investigated directed to single targets, namely inhibitors of β and γ secretase, vaccines or antibodies that clear Aβ, metal chelators to inhibit Aβ aggregation, blockers of glycogen synthase kinase 3β, enhancers of mitochondrial function, antioxidants, modulators of calcium-permeable channels such as voltage-dependent calcium channels, N-methyl-D-aspartate receptors for glutamate, or enhancers of cholinergic neurotransmission such as inhibitors of acetylcholinesterase or butyrylcholinesterase.  In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compd. targeting two or more of the pathogenic mechanisms leading to neuronal death.  This review summarizes the current therapeutic strategies based on the paradigm one-compd.-various targets to treat AD.  A treatment that delays disease onset and/or progression by 5 years could halve the no. of people requiring institutionalization and/or dying from AD.  © 2011 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YQ_Czzj5brVg90H21EOLACvtfcHk0lj662daqtGGFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL&md5=b08806a8a4ca71c35a3594338c881e74</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fmed.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20248%26sid%3Dliteratum%253Aachs%26aulast%3DLeon%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520multitarget-directed%2520ligands%2520approach%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189%26doi%3D10.1002%2Fmed.20248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Dias, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viegas, C.,  Jr.</span><span> </span><span class="NLM_article-title">Multi-target directed drugs: A modern approach for design of new drugs for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.2174/1570159X1203140511153200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.2174%2F1570159X1203140511153200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=24851088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A280%3ADC%252BC2cjltFSqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=239-255&author=K.+S.+Diasauthor=C.+Viegas&title=Multi-target+directed+drugs%3A+A+modern+approach+for+design+of+new+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1570159X1203140511153200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer's Disease</span></div><div class="casAuthors">Dias Kris Simone Tranches; Viegas Claudio Jr</div><div class="citationInfo"><span class="NLM_cas:title">Current neuropharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-55</span>
        ISSN:<span class="NLM_cas:issn">1570-159X</span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a complex neurodegenerative disorder with a multi-faceted pathogenesis.  So far, the therapeutic paradigm "one-compound-one-target" has failed and despite enormous efforts to elucidate the pathophysiology of AD, the disease is still incurable.  The multiple factors involved in AD include amyloid aggregation to form insoluble neurotoxic plaques of Aβ, hyperphosphorylation of tau protein, oxidative stress, calcium imbalance, mitochondrial dysfunction and deterioration of synaptic transmission.  These factors together, accentuate changes in the CNS homeostasis, starting a complex process of interconnected physiological damage, leading to cognitive and memory impairment and neuronal death.  A recent approach for the rational design of new drug candidates, also called multitarget-directed ligand (MTDL) approach, has gained increasing attention by many research groups, which have developed a variety of hybrid compounds acting simultaneously on diverse biological targets.  This review aims to show some recent advances and examples of the exploitation of MTDL approach in the rational design of novel drug candidate prototypes for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYe5S6uW60kOR_TJajKxJDfW6udTcc2eYt_xBXFGiKcrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjltFSqtg%253D%253D&md5=799f606126ae0ca12411a25515de14e2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F1570159X1203140511153200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X1203140511153200%26sid%3Dliteratum%253Aachs%26aulast%3DDias%26aufirst%3DK.%2BS.%26aulast%3DViegas%26aufirst%3DC.%26atitle%3DMulti-target%2520directed%2520drugs%253A%2520A%2520modern%2520approach%2520for%2520design%2520of%2520new%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2014%26volume%3D12%26spage%3D239%26epage%3D255%26doi%3D10.2174%2F1570159X1203140511153200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Multi-target directed donepezil-like ligands for Alzheimer’s disease</span> <span class="citation_source-journal">Front. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="refDoi"> DOI: 10.3389/fnins.2016.00205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.3389%2Ffnins.2016.00205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=27252617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FmtV2hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=205&author=M.+Unzetaauthor=G.+Estebanauthor=I.+Boleaauthor=W.+A.+Fogelauthor=R.+R.+Ramsayauthor=M.+B.+Youdimauthor=K.+F.+Tiptonauthor=J.+Marco-Contelles&title=Multi-target+directed+donepezil-like+ligands+for+Alzheimer%E2%80%99s+disease&doi=10.3389%2Ffnins.2016.00205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease</span></div><div class="casAuthors">Unzeta Mercedes; Bolea Irene; Esteban Gerard; Tipton Keith F; Fogel Wieslawa A; Ramsay Rona R; Youdim Moussa B H; Marco-Contelles Jose</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">205</span>
        ISSN:<span class="NLM_cas:issn">1662-4548</span>.
    </div><div class="casAbstract">HIGHLIGHTS ASS234 is a MTDL compound containing a moiety from Donepezil and the propargyl group from the PF 9601N, a potent and selective MAO B inhibitor.  This compound is the most advanced anti-Alzheimer agent for preclinical studies identified in our laboratory.Derived from ASS234 both multipotent donepezil-indolyl (MTDL-1) and donepezil-pyridyl hybrids (MTDL-2) were designed and evaluated as inhibitors of AChE/BuChE and both MAO isoforms.  MTDL-2 showed more high affinity toward the four enzymes than MTDL-1.MTDL-3 and MTDL-4, were designed containing the N-benzylpiperidinium moiety from Donepezil, a metal- chelating 8-hydroxyquinoline group and linked to a N-propargyl core and they were pharmacologically evaluated.The presence of the cyano group in MTDL-3, enhanced binding to AChE, BuChE and MAO A.  It showed antioxidant behavior and it was able to strongly complex Cu(II), Zn(II) and Fe(III).MTDL-4 showed higher affinity toward AChE, BuChE.MTDL-3 exhibited good brain penetration capacity (ADMET) and less toxicity than Donepezil.  Memory deficits in scopolamine-lesioned animals were restored by MTDL-3.MTDL-3 particularly emerged as a ligand showing remarkable potential benefits for its use in AD therapy.  Alzheimer's disease (AD), the most common form of adult onset dementia, is an age-related neurodegenerative disorder characterized by progressive memory loss, decline in language skills, and other cognitive impairments.  Although its etiology is not completely known, several factors including deficits of acetylcholine, β-amyloid deposits, τ-protein phosphorylation, oxidative stress, and neuroinflammation are considered to play significant roles in the pathophysiology of this disease.  For a long time, AD patients have been treated with acetylcholinesterase inhibitors such as donepezil (Aricept®) but with limited therapeutic success.  This might be due to the complex multifactorial nature of AD, a fact that has prompted the design of new Multi-Target-Directed Ligands (MTDL) based on the "one molecule, multiple targets" paradigm.  Thus, in this context, different series of novel multifunctional molecules with antioxidant, anti-amyloid, anti-inflammatory, and metal-chelating properties able to interact with multiple enzymes of therapeutic interest in AD pathology including acetylcholinesterase, butyrylcholinesterase, and monoamine oxidases A and B have been designed and assessed biologically.  This review describes the multiple targets, the design rationale and an in-house MTDL library, bearing the N-benzylpiperidine motif present in donepezil, linked to different heterocyclic ring systems (indole, pyridine, or 8-hydroxyquinoline) with special emphasis on compound ASS234, an N-propargylindole derivative.  The description of the in vitro biological properties of the compounds and discussion of the corresponding structure-activity-relationships allows us to highlight new issues for the identification of more efficient MTDL for use in AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAKdUtVDXRPgpJitSxOdIlfW6udTcc2eYt_xBXFGiKcrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FmtV2hsw%253D%253D&md5=0904cb1e4e1c700e575e192e9d3bebb3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3389%2Ffnins.2016.00205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnins.2016.00205%26sid%3Dliteratum%253Aachs%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DEsteban%26aufirst%3DG.%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DFogel%26aufirst%3DW.%2BA.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DMulti-target%2520directed%2520donepezil-like%2520ligands%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Neurosci.%26date%3D2016%26volume%3D10%26spage%3D205%26doi%3D10.3389%2Ffnins.2016.00205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Navigating the chemical space of multitarget-directed ligands: From hybrids to fragments in Alzheimer’s disease</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="refDoi"> DOI: 10.3390/molecules21040466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.3390%2Fmolecules21040466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=27070562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWktLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=466&author=F.+Pratiauthor=A.+Cavalliauthor=M.+L.+Bolognesi&title=Navigating+the+chemical+space+of+multitarget-directed+ligands%3A+From+hybrids+to+fragments+in+Alzheimer%E2%80%99s+disease&doi=10.3390%2Fmolecules21040466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Navigating the chemical space of multitarget-directed ligands: from hybrids to fragments in Alzheimer's disease</span></div><div class="casAuthors">Prati, Federica; Cavalli, Andrea; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">466/1-466/12</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Multitarget drug discovery is one of the hottest topics and most active fields in the search for new mols. against Alzheimer's disease (AD).  Over the last 20 years, many promising multitarget-directed ligands (MTDLs) have been identified and developed at a pre-clin. level.  However, how to design them in a rational way remains the most fundamental challenge of medicinal chemists.  This is related to the foundational question of achieving an optimized activity towards multiple targets of interest, while preserving drug-like properties.  In this respect, large hybrid mols. and small fragments are poles apart.  In this review article, our aim is to appraise what we have accomplished in the development of both hybrid- and fragment-like mols. directed to diverse AD targets (i.e., acetylcholinesterase, NMDA receptors, metal chelation, BACE-1 and GSK-3β).  In addn., we attempt to highlight what are the persistent needs that deserve to be improved and cared for, with the ultimate goal of moving an MTDL to AD clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAXsoof4raqbVg90H21EOLACvtfcHk0lgMjmR_u-ABEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWktLjI&md5=3653a0ef6b41711663e8d2f2d4ae74f6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21040466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21040466%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DNavigating%2520the%2520chemical%2520space%2520of%2520multitarget-directed%2520ligands%253A%2520From%2520hybrids%2520to%2520fragments%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D466%26doi%3D10.3390%2Fmolecules21040466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Rizzo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riviere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morroni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, beta amyloid aggregation, and abeta neurotoxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2883</span><span class="NLM_x">–</span> <span class="NLM_lpage">2886</span><span class="refDoi"> DOI: 10.1021/jm8002747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8002747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2883-2886&author=S.+Rizzoauthor=C.+Riviereauthor=L.+Piazziauthor=A.+Bisiauthor=S.+Gobbiauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=F.+Morroniauthor=A.+Tarozziauthor=J.+P.+Montiauthor=A.+Rampa&title=Benzofuran-based+hybrid+compounds+for+the+inhibition+of+cholinesterase+activity%2C+beta+amyloid+aggregation%2C+and+abeta+neurotoxicity&doi=10.1021%2Fjm8002747"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm8002747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8002747%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DS.%26aulast%3DRiviere%26aufirst%3DC.%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DMorroni%26aufirst%3DF.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DJ.%2BP.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DBenzofuran-based%2520hybrid%2520compounds%2520for%2520the%2520inhibition%2520of%2520cholinesterase%2520activity%252C%2520beta%2520amyloid%2520aggregation%252C%2520and%2520abeta%2520neurotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2883%26epage%3D2886%26doi%3D10.1021%2Fjm8002747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Rizzo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Costa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligresti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrelia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">2-arylbenzofuran-based molecules as multipotent Alzheimer’s disease modifying agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.10.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1016%2Fj.ejmech.2012.10.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2012&pages=519-532&author=S.+Rizzoauthor=A.+Tarozziauthor=M.+Bartoliniauthor=G.+Da+Costaauthor=A.+Bisiauthor=S.+Gobbiauthor=F.+Bellutiauthor=A.+Ligrestiauthor=M.+Allaraauthor=J.+P.+Montiauthor=V.+Andrisanoauthor=V.+Di+Marzoauthor=P.+Hreliaauthor=A.+Rampa&title=2-arylbenzofuran-based+molecules+as+multipotent+Alzheimer%E2%80%99s+disease+modifying+agents&doi=10.1016%2Fj.ejmech.2012.10.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.10.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.10.045%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DS.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDa%2BCosta%26aufirst%3DG.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DAllara%26aufirst%3DM.%26aulast%3DMonti%26aufirst%3DJ.%2BP.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DHrelia%26aufirst%3DP.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3D2-arylbenzofuran-based%2520molecules%2520as%2520multipotent%2520Alzheimer%25E2%2580%2599s%2520disease%2520modifying%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D58%26spage%3D519%26epage%3D532%26doi%3D10.1016%2Fj.ejmech.2012.10.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Pan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.-M.</span><span> </span><span class="NLM_article-title">An efficient method to synthesize benzofurans and naphthofurans</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1657</span><span class="NLM_x">–</span> <span class="NLM_lpage">1662</span><span class="refDoi"> DOI: 10.1055/s-2006-944204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1055%2Fs-2006-944204" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=1657-1662&issue=11&author=C.+Panauthor=J.+Yuauthor=Y.+Zhouauthor=Z.+Wangauthor=M.-M.+Zhou&title=An+efficient+method+to+synthesize+benzofurans+and+naphthofurans&doi=10.1055%2Fs-2006-944204"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-944204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-944204%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DM.-M.%26atitle%3DAn%2520efficient%2520method%2520to%2520synthesize%2520benzofurans%2520and%2520naphthofurans%26jtitle%3DSynlett%26date%3D2006%26volume%3D2006%26issue%3D11%26spage%3D1657%26epage%3D1662%26doi%3D10.1055%2Fs-2006-944204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lorenzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yankner, B. A.</span><span> </span><span class="NLM_article-title">Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">12243</span><span class="NLM_x">–</span> <span class="NLM_lpage">12247</span><span class="refDoi"> DOI: 10.1073/pnas.91.25.12243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1073%2Fpnas.91.25.12243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=7991613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADyaK2MXisF2jsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=12243-12247&author=A.+Lorenzoauthor=B.+A.+Yankner&title=Beta-amyloid+neurotoxicity+requires+fibril+formation+and+is+inhibited+by+congo+red&doi=10.1073%2Fpnas.91.25.12243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red</span></div><div class="casAuthors">Lorenzo, Alfredo; Yankner, Bruce A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">12243-7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">β-Amyloid (βA) is normally produced as a nontoxic sol. peptide.  In Alzheimer disease, βA aggregates and accumulates in the brain as inert diffuse plaques or compact plaques assocd. with neurodegenerative changes.  To det. the relation of neurotoxicity to the phys. state of βA, the authors created (i) nonamyloidogenic amorphous aggregates of βA [amorphous βA (Am-βA)] analogous to diffuse plaques and (ii) amyloidogenic fibrils of βA [fibrillar βA (Fib-βA)] analogous to compact plaques.  In primary rat hippocampal culture, Fib-βA was neurotoxic, whereas Am-βA was not toxic.  Fib-βA caused significant loss of synapses in viable neurons, while Am-βA had no effect on synapse no.  The amyloid fibril-binding dye Congo red inhibited Fib-βA neurotoxicity by inhibiting fibril formation or by binding to preformed fibrils.  Congo red also inhibited the pancreatic islet cell toxicity of diabetes-assocd. amylin, another type of amyloid fibril.  These results indicate that βA neurotoxicity requires fibril formation.  These findings and the authors previous demonstration that amylin fibrils are toxic suggest that a common cytopathic effect of amyloid fibrils may contribute to the pathogenesis of Alzheimer disease and other amyloidoses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1ScYUorh19rVg90H21EOLACvtfcHk0lioqkH4e8LZbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXisF2jsL4%253D&md5=b38ab117cc8a54b20c315a02ca92ea1f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.25.12243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.25.12243%26sid%3Dliteratum%253Aachs%26aulast%3DLorenzo%26aufirst%3DA.%26aulast%3DYankner%26aufirst%3DB.%2BA.%26atitle%3DBeta-amyloid%2520neurotoxicity%2520requires%2520fibril%2520formation%2520and%2520is%2520inhibited%2520by%2520congo%2520red%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D12243%26epage%3D12247%26doi%3D10.1073%2Fpnas.91.25.12243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Song, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, T.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, H.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huh, S.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paek, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, Y.-H.</span><span> </span><span class="NLM_article-title">Behavioral and neuropathologic changes induced by central injection of carboxyl-terminal fragment of β-amyloid precursor protein in mice</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">878</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.1998.71020875.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1046%2Fj.1471-4159.1998.71020875.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=9681480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=1%3ACAS%3A528%3ADyaK1cXkslKksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1998&pages=875-878&author=D.-K.+Songauthor=M.-H.+Wonauthor=J.-S.+Jungauthor=J.-C.+Leeauthor=T.-C.+Kangauthor=H.-W.+Suhauthor=S.-O.+Huhauthor=S.-H.+Paekauthor=Y.-H.+Kimauthor=S.-H.+Kimauthor=Y.-H.+Suh&title=Behavioral+and+neuropathologic+changes+induced+by+central+injection+of+carboxyl-terminal+fragment+of+%CE%B2-amyloid+precursor+protein+in+mice&doi=10.1046%2Fj.1471-4159.1998.71020875.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral and neuropathologic changes induced by central injection of carboxyl-terminal fragment of β-amyloid precursor protein in mice</span></div><div class="casAuthors">Song, D. K.; Won, M. H.; Jung, J. S.; Lee, J. C.; Kang, T. C.; Suh, H. W.; Huh, S. O.; Paek, S. H.; Kim, Y. H.; Kim, S. H.; Suh, Y. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">875-878</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">Expression of the carboxyl-terminal fragment (CT) of the β-amyloid precursor protein (APP) in transgenic animals has been linked with neurotoxicity.  However, it remains to be clarified whether the neurotoxicity is caused by β-amyloid proteins (Aβs) derived from CT or by CT itself.  To study the in vivo neurotoxicity of CT, mice were given a single intracerebroventricular injection of a recombinant 105-amino acid CT (CT105; 68.5-685 pmol, intracerebroventricularly), and changes in behavior and in brain histol. were examd.  Animals given CT105 (410 or 685 pmol, intracerebroventricularly) showed a dose-dependent impairment in the passive avoidance performance, whereas boiled CT105 had no effect.  CT105 (685 pmol, intracerebroventricularly) induced reactive gliosis in neocortex and hippocampus and neurodegeneration in neocortex.  These results indicate that centrally administered CT105 induces behavioral impairment and neuropathol. changes, suggesting a direct toxic effect of CT105 per se.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp372URWd1pybVg90H21EOLACvtfcHk0lhBT9d98pdZDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkslKksbs%253D&md5=5598c8ae756d5e77fb7493f9e8ccaebf</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1998.71020875.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1998.71020875.x%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DD.-K.%26aulast%3DWon%26aufirst%3DM.-H.%26aulast%3DJung%26aufirst%3DJ.-S.%26aulast%3DLee%26aufirst%3DJ.-C.%26aulast%3DKang%26aufirst%3DT.-C.%26aulast%3DSuh%26aufirst%3DH.-W.%26aulast%3DHuh%26aufirst%3DS.-O.%26aulast%3DPaek%26aufirst%3DS.-H.%26aulast%3DKim%26aufirst%3DY.-H.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DSuh%26aufirst%3DY.-H.%26atitle%3DBehavioral%2520and%2520neuropathologic%2520changes%2520induced%2520by%2520central%2520injection%2520of%2520carboxyl-terminal%2520fragment%2520of%2520%25CE%25B2-amyloid%2520precursor%2520protein%2520in%2520mice%26jtitle%3DJ.%2520Neurochem.%26date%3D1998%26volume%3D71%26spage%3D875%26epage%3D878%26doi%3D10.1046%2Fj.1471-4159.1998.71020875.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Cheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBlanc, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span> </span><span class="NLM_article-title">Triptolide preserves cognitive function and reduces neuropathology in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e108845</span><span class="refDoi"> DOI: 10.1371/journal.pone.0108845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;key=10.1371%2Fjournal.pone.0108845" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e108845&author=S.+Chengauthor=K.+J.+LeBlancauthor=L.+Li&title=Triptolide+preserves+cognitive+function+and+reduces+neuropathology+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0108845"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0108845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0108845%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DS.%26aulast%3DLeBlanc%26aufirst%3DK.%2BJ.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DTriptolide%2520preserves%2520cognitive%2520function%2520and%2520reduces%2520neuropathology%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De108845%26doi%3D10.1371%2Fjournal.pone.0108845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i20"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00844">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_40362"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00844">10.1021/acs.jmedchem.7b00844</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Detailed experimental procedures for in vitro assays and in vivo animal studies (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00844/suppl_file/jm7b00844_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00844/suppl_file/jm7b00844_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00844/suppl_file/jm7b00844_si_001.pdf">jm7b00844_si_001.pdf (220.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00844/suppl_file/jm7b00844_si_002.csv">jm7b00844_si_002.csv (0.34 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00844&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00844" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00844" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679912953b2025a5","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
